Iron(III) chloride modulated selective 1,2-trans glycosylation based on glycosyl trichloroacetimidate donors and its application in orthogonal glycosylation

Mana Mohan Mukherjee, Nabamita Basu and Rina Ghosh*
Department of Chemistry, Jadavpur University, Jadavpur, Kolkata 700032, West Bengal, India. E-mail: ghoshrina@yahoo.com

Received 31st August 2016 , Accepted 26th October 2016

First published on 27th October 2016


Abstract

The development of a new glycosylation method for efficient stereoselective synthesis of β-gluco- and galactosides from their corresponding armed trichloroacetimidate donors mediated by 10 mole% of FeCl3 has been focused. FeCl3 has also been applied to a number of glucose, galactose, mannose and rhamnose based trichloroacetimidate donors with various protecting groups incorporated at the C-2-position to prepare a variety of disaccharides and trisaccharides with excellent 1,2-trans selectivity. FeCl3 can also modulate the 1,2-trans selectivity of the reaction of 2-O-alkylated gluco- and galacto-pyranosyl trichloroacetimidates with phenolic compounds leading to the generation of the corresponding β-O-aryl glycosides in excellent yield and selectivity. Apart from these the present methodology has been successfully utilized for double glycosylation and orthogonal glycosylation reactions along with its application in one-pot three component orthogonal glycosylation reactions for synthesis of a trisaccharide.


Introduction

Beyond their traditionally accepted roles as energy sources and structural polymers, oligosaccharides and glycoconjugates serve critical roles in a wide range of biological processes like viral and bacterial infection, angiogenesis and tumour cell metastasis, toxin interaction, inflammation and immune response, cell growth and proliferation, and many other cell–cell communications.1 However, such carbohydrates are difficult to isolate from natural sources with acceptable purity and in satisfactory quantities. The key step in the synthesis of oligosaccharides is the formation of the glycosidic linkages between monosaccharide units. The anomeric stereoselectivity can be controlled by the use of protecting groups that are capable of neighbouring group participation. For example, esters at the C-2 position of a glycosyl donor typically provide high selectivity for the 1,2-trans glycoside product. Occasionally, however, it suffers from several drawbacks too, such as low reactivity of the ester protected glycosyl donor prolonging reaction time and lowering of yield,2 competitive formation of 1,2-ortho ester3 and migration of C-2 ester functionality to other positions.4

Stereocontrol in the absence of usual neighbouring O-acyl group participation is considerably more challenging. Many factors, such as steric hindrance of protecting groups, reaction solvent, and temperature can affect the stereochemical outcome of a glycosylation reaction, and these effects are typically difficult to predict for any given donor–acceptor pair. So, better methods to control stereoselectivity in the absence of neighbouring ester group participation are also needed.

On the other hand, β-O-aryl glycosides have been recently found to exhibit anti tumour, anti HIV and anti bacterial activities. β-O-Aryl glycoside formation is considered as a difficult task due to electron withdrawing power of the aromatic ring, the facile rearrangement of the resulting O-aryl glycosides to their corresponding C-aryl glycosides and steric hindrance from substituents on phenolic glycosyl acceptors;5 hence their stereo-controlled synthesis has become a challenging job.6 Glycosyl acetates, halides and trichloroacetimidates (TCA) have been used as donors in the formation of β-O-aryl glycosides.6 Glycosyl acetates usually provide the β-O-aryl glycosides with lower yields than trichloroacetimidates due to anomerization of both the glycosyl donor and the coupling product.6 The β-O-aryl glycosides can be formed in the glycosylation reaction by employing ester functionalities as the directing group at the C-2 position of glycosyl donors. In some cases, formation of orthoester side products and migration of the C-2-O-acyl functionality are also observed in the reaction.3,7

Since the first paper on Schmidt's glycosylation method was published in 1980,8a,b till date trichloroacetimidates have been among the most widely used glycosyl donors.8c Their popularity comes from their relative ease of synthesis by base-catalyzed addition of trichloroacetonitrile to the anomeric hydroxy group9 and their easy activation; it also opens up the scope for orthogonal glycosylation. The glycosyl trichloroacetimidate donors are generally activated by strong Lewis acids such as BF3·OEt2,8a TMSOTf,9a Tf2O,10 ZnBr2,11 NOBF4,12 Sm(OTf)3,13a LiClO4,14 LiOTf,15 or other systems like I2/Et3SiH,13b acid washed 4 Å molecular sieves,13c,d HClO4/SiO2,16 Amberlyst 15,17 AuCl3–phenylacetylene,18 etc.; many of these are however not without limitations.

Results and discussion

Recently Nguyen et al.19 have reported trichloroacetimidate (TCA, containing 2-O-alkyl group) activation in high to excellent 1,2-trans selectivity utilizing second row transition metal complexes involving Pd in low catalyst loading. In another report chiral Brønsted acid has been utilized for such purpose.20 In a more recent report by Schmidt et al. it has been demonstrated that β-glycosylation based on armed trichloroacetimidate donors using Au(III) or Au(I) chloride catalyst via formation of catalyst-glycosyl acceptor adduct permits glycosyl donor activation with concomitant glycosyl acceptor anion transfer to the anomeric carbon.21 But the reported catalysts are very much expensive, and sometimes toxic for the living body as well as environment. In continuation of our research work on glycoscience,22 we report herein a 1,2-trans glycosylation protocol using FeCl3 as a green catalyst. Unlike all other reported glycosylation methods (except the reports made by Nguyen et al.19 and by Schmidt et al.21) based on armed trichloroacetimidate glycosyl donors the present one generated the corresponding glycosides in excellent yields and 1,2-trans selectivity (Scheme 1). The acceptable catalyst load and low cost (Scheme 1) of FeCl3 together with its greenness particularly in respect of the scope of its future utilization for large scale ramification make this procedure very attractive.
image file: c6ra21859h-s1.tif
Scheme 1 Comparison of the recent works with the present one (inset).

In the last decade FeCl3 has drawn much attention of the researchers worldwide for its wide range of application in organic synthesis.23 Our strategy for 1,2-trans glycosylation was to exploit the ability of this first row transition metal-Lewis acids to direct glycosylation of trichloroacetimidate donor. The choice of FeCl3 was based on the presumption that, for glucose and galactose donors, like Pd a seven member cyclic chelate19,24 (b) may be the possibility involving electronically vacant metal center (Fe), α-imidate nitrogen and C-2-oxygen of glycosyl trichloroacetimidate donor (a) which in effect would block the α-face of the proposed TS (c) for the attacking incoming nucleophilic acceptor, so that ultimately it can result in β-glycoside (d), vide Fig. 1.


image file: c6ra21859h-f1.tif
Fig. 1 Anticipated transition states for FeCl3 catalyzed glucose and galactose based armed donors.

Our initial study was performed with 2,3,4,6-tetra-O-benzyl-D-glucopyranosyl trichloroacetimidate, 1 as the armed glycosyl donor and methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside 2 as the acceptor. Upon treatment of these coupling partners in 1.2[thin space (1/6-em)]:[thin space (1/6-em)]1 molar ratio with 30 mole% FeCl3 at −5 °C to room temperature for 1 hour, the desired disaccharide 3 was isolated in 67% yield as a single β isomer. 1H-NMR spectrum showed one anomeric proton appearing at δ 4.55 ppm with J 8.0 Hz corresponding to the H′1 indicating 1,2-trans glycosylation. This was also corroborated by the appearance of peaks at δ 101.9 and 104.0 ppm, corresponding to the anomeric carbons C′1 and C1, respectively. Higher δ value of the reducing anomeric carbon, in spite of it having an α-stereochemistry is attributed to the deshielding caused by three benzoyl protections on this pyranoside ring. The result, as we presumed, was indeed interesting and encouraging too, as this was clearly implying the ability of FeCl3 to activate trichloroacetimidate stereoselectively in the presence of apparently silent spectator protecting group like O-benzyl or without assistance by the solvent.

As an initial effort for optimization of a standard procedure for glycosylation we applied different catalyst loading (of FeCl3) with variation in temperature and solvent, as well as few other catalysts too (Table 1). Finally we selected the most economically acceptable and efficient reaction condition as 10 mole% FeCl3 at −60 °C to room temperature and used the process for further studies.

Table 1 Standardization of optimum reaction conditiona

image file: c6ra21859h-u1.tif

Entry Catalyst (mole%) Reaction temperature Time Yieldb (α/β ratio)c
a All reactions were carried out in DCM with 1.2 equiv. of donor.b Isolated yield.c 1H NMR ratio.d Using MeCN[thin space (1/6-em)]:[thin space (1/6-em)]DCM (1[thin space (1/6-em)]:[thin space (1/6-em)]2).e Using Et2O[thin space (1/6-em)]:[thin space (1/6-em)]DCM (1[thin space (1/6-em)]:[thin space (1/6-em)]1).f Using 99.99% FeCl3 of Sigma Aldrich.g Using β anomer of 1 as donor.
1 FeCl3 (30) −5 °C to rt 1 h 67% (β only)
2 FeCl3 (20) −30 °C to rt 45 min 72% (β only)
3 FeCl3 (30) −60 °C to rt 45 min 83% (β only)
4 FeCl3 (20) −60 °C to rt 45 min 90% (β only)
5 FeCl3 (10) −60 °C to rt 45 min 96% (β only)
6 FeCl3 (5) −60 °C to rt 45 min 92% (β only)
7 FeCl3 (10) −80 °C to rt 45 min 94% (β only)
8 FeCl3 (10) −60 °C to rt 45 min 94% (β only)d
9 FeCl3 (10) −60 °C to rt 45 min 93% (2[thin space (1/6-em)]:[thin space (1/6-em)]3)e
10 FeCl3 (10) −60 °C to rt 45 min 94% (β only)f
11 FeCl3 (10) −60 °C to rt 35 min 93% (β only)g
12 FeBr3 (30) −50 °C to rt 45 min 59% (1[thin space (1/6-em)]:[thin space (1/6-em)]9)
13 In(OTf)3 (30) −50 °C to rt 45 min 62% (β only)


With an optimized reaction condition in hand we then set out to explore the scope of FeCl3 catalyzed 1,2-trans selective glycosylations. A variety of nucleophilic glycosyl acceptors incorporating various protecting groups like ether, isopropylidene ketals and benzylidene acetals were exemplified with glycosyl donor 1 (Table 2). Glycosyl acceptors with least reactive 4-OH, hindered tertiary alcohol like 1-adamentanol and sensitive diisopropylidene protection (4, 6 and 8, respectively) in reaction with 1 generated the corresponding disaccharides 5, 7 and 9 in excellent yields (entries 2, 3 and 4, Table 2), with notable β selectivity compared to the reported ones.13a,19b,c The structure of compound 7 (CCDC no. 1501233) was confirmed by its X-ray structure (Fig. 2).

Table 2 Glycosylation with C-2 alkyl donorsa
Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β) Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β)
a All reactions were carried out in dry DCM with 1.2 equiv. of donor at −60 °C to rt.b Isolated yield.c Use of glycosyl donor in 1.5 g scale.d Reaction was carried out at −5 °C to rt.
1 image file: c6ra21859h-u2.tif image file: c6ra21859h-u3.tif image file: c6ra21859h-u4.tif 96% β (89%)c 6 image file: c6ra21859h-u5.tif 2 image file: c6ra21859h-u6.tif 95% β
2 1 image file: c6ra21859h-u7.tif image file: c6ra21859h-u8.tif 93% β 7 12 4 image file: c6ra21859h-u9.tif 88% β
3 1 image file: c6ra21859h-u10.tif image file: c6ra21859h-u11.tif 94% β 8 12 image file: c6ra21859h-u12.tif image file: c6ra21859h-u13.tif 89% β
9 12 image file: c6ra21859h-u14.tif image file: c6ra21859h-u15.tif 90% β
4 1 image file: c6ra21859h-u16.tif image file: c6ra21859h-u17.tif 85% β 10 image file: c6ra21859h-u18.tif 4 image file: c6ra21859h-u19.tif 87% αd
5 image file: c6ra21859h-u20.tif 8 image file: c6ra21859h-u21.tif 87% β 11 image file: c6ra21859h-u22.tif image file: c6ra21859h-u23.tif image file: c6ra21859h-u24.tif 92% β



image file: c6ra21859h-f2.tif
Fig. 2 ORTEP diagram of compound 7.

The efficacy of the present procedure was further established when we examined this chemistry with 2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl trichloroacetimidate 12; the armed donor is well known for its α-directive effect for 4 axial –OH group. Compared to other reported methods,25,26 we observed remarkable β selectivity when glycosylation reactions of 12 were performed with carbohydrate acceptors 2, 4, 15 and 17 having nucleophilic hydroxy group on C-6, C-4, C-3 and C-2 positions, respectively; irrespective of their position and reactivity, the corresponding desired disaccharides (13, 14, 16 and 18) were obtained in excellent yield and β selectivity (entries 6 to 9, Table 2).

The present method also responded efficiently under a scale-up (∼30 fold) condition when applied for preparation of 3 from reaction of 1 and 2 (entry 1, Table 2), thus opening up scope to apply this method for preparative purpose also. When 4,6-O-benzylidene-2,3-di-O-benzyl-α-D-glucopyranosyl trichloroacetimidate donor, 10 reacted with acceptor 8 the desired disaccharide 11 was obtained in 87% yield as β isomer; the reaction of it's galactose analogue 21 with acceptor 22 gave the β-disaccharide 23 in 92% yield (entries 5 and 11, respectively, Table 2). When armed D-mannopyranosyl trichloroacetimidate donor 19 was allowed to react with nucleophilic acceptor 4, the corresponding α-disaccharide 20 was obtained in high yield (entry 10, Table 2).

The other glycosyl trichloroacetimidate donor systems that needed to be exercised in FeCl3 catalyzed glycosylation protocol were those with C-2-O-acyl protecting donors. It is expected that ester functionality from C-2 position might control the formation of 1,2-trans through the usual neighbouring group participation. Glycosylation of donors 24, 27, 29, 32, 34, and 36 with a variety of glycosyl acceptors like 25, 30 and 2 separately (entries 1 to 6, Table 3) provided the corresponding 1,2-trans selective products 26, 28, 31, 33, 35 and 37.

Table 3 Glycosylation with C-2 ester protected sugara
Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β)
a All reactions were performed in dry DCM with 1.2 equiv. of donor and 10 mole% of FeCl3 at −60 °C to rt.b Isolated yield.
1 image file: c6ra21859h-u25.tif image file: c6ra21859h-u26.tif image file: c6ra21859h-u27.tif 90% α only
2 image file: c6ra21859h-u28.tif 25 image file: c6ra21859h-u29.tif 89% α only
3 image file: c6ra21859h-u30.tif image file: c6ra21859h-u31.tif image file: c6ra21859h-u32.tif 91% β only
4 image file: c6ra21859h-u33.tif 30 image file: c6ra21859h-u34.tif 91% β only
5 image file: c6ra21859h-u35.tif 2 image file: c6ra21859h-u36.tif 88% β only
6 image file: c6ra21859h-u37.tif 2 image file: c6ra21859h-u38.tif 90% β only


To further demonstrate the efficacy of the glycosylation protocol, we set out to pursue a glycosylation reaction of donor 1 with a disaccharide acceptor 38, where we get the trisaccharide, 39 in 89% yield and as β anomer. It is to be noted here that the reported method using Pd(PhCN)2Cl2 + AgOTf produces the trisaccharide 39 in 71% yield with β[thin space (1/6-em)]:[thin space (1/6-em)]α = 12[thin space (1/6-em)]:[thin space (1/6-em)]1 anomeric ratio.19c Then we turned to a couple of double glycosylation of carbohydrate diol. Pair up of 4,6-glucopyranosyl diol 41 and phthalimide protected glucosamine donor 40, resulted with the desired trisaccharide 42 in 83% yield where as the same diol acceptor 41 reacted with the rhamnosyl donor 27 affording 81% of the desired trisaccharide 43 (Scheme 2).


image file: c6ra21859h-s2.tif
Scheme 2 Glycosylation with disaccharide acceptor and double glycosylations.

Next, we turned our attention to apply the present protocol for the synthesis of β-aryl glycosides. FeCl3 catalyzed β-selective arylation was found effective for D-glucopyranosyl trichloroacetimidate donor 1 with a variety of electron-rich phenols (44, 46 and 50), and the corresponding desired glycosides 45, 47 and 51 were isolated in excellent yield and β-selectivity (entries 1, 2 and 4, Table 4). Similarly, tetra-O-benzyl-D-galactopyranosyl trichloroacetimidate substrate 12 was also examined under the standardized condition to react with different phenols 44, 53, and 55; in each case we found the corresponding desired β-O-aryl galactoside 52, 54 and 56 to be formed with promising result on the ground of yield and selectivity (entries 5 to 7, Table 4).

Table 4 Glycosylation with different phenola
Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β)
a All reactions were performed in dry DCM with 1.2 equiv. of donor and 10 mole% of FeCl3 at −5 °C to rt.b Isolated yield.
1 1 image file: c6ra21859h-u39.tif image file: c6ra21859h-u40.tif 97% β
2 1 image file: c6ra21859h-u41.tif image file: c6ra21859h-u42.tif 97% β
3 1 image file: c6ra21859h-u43.tif image file: c6ra21859h-u44.tif 90% β
4 1 image file: c6ra21859h-u45.tif image file: c6ra21859h-u46.tif 92% β
5 12 44 image file: c6ra21859h-u47.tif 97% β
6 12 image file: c6ra21859h-u48.tif image file: c6ra21859h-u49.tif 95% β
7 12 image file: c6ra21859h-u50.tif image file: c6ra21859h-u51.tif 94% β
8 12 48 image file: c6ra21859h-u52.tif 91% β


To explore further the applicability of this procedure we then chose a sterically hindered 2,6-dimethylphenol 48. Gratifyingly, this phenol acceptor 48 was able to couple with both donors 1 and 12 to provide the corresponding O-aryl glycosides 49 and 57, respectively with excellent yield and anomeric selectivity (entries 3 and 8, Table 4). It may be mentioned here that the reported coupling between phenol 48 and tetra-O-benzyl-D-glucothioglycoside donor affords the desired product 49 with excellent yield (90%) albeit with low selectivity (α[thin space (1/6-em)]:[thin space (1/6-em)]β = 2.6[thin space (1/6-em)]:[thin space (1/6-em)]1),27a whereas the sulfoxide approach gave 70% yield as a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 mixture of α- and β-anomer.27b

After achieving a convenient synthetic route for 1,2-trans selective glycosylation with trichloroacetemidate donors, we also sought to verify the efficiency of the Lewis acidity of FeCl3 to promote thioglycoside activation in combination with NIS. For this purpose thioglycoside donors 58, 61, 63 and 66 were allowed to couple with benzyl N-(3-hydroxypropyl) carbamate 59 (entries 1 and 2, Table 5), 1-adamentanol 6 (entries 3 and 4, Table 5) and carbohydrate acceptor like 4 (entry 5, Table 5) to produce the corresponding glycosides 60, 62, 64, 65 and 67 in excellent respective yield and expected β-steroselectivity due to C-2 neighbouring group participation. A rare sugar derivative of D-rhamnose donor 68 was allowed to couple with similar acceptor 69 to give stereoselectively the desired disaccharide 70 in 91% yield (entry 6, Table 5). Reaction of mannosyl donor 71 with di-mannoside acceptor 72 produces the mannose trisaccharide 73 in 90% yield (entry 7, Table 5). These reactions thus prove the ability of FeCl3 to catalyse thioglycoside activation too, in combination with NIS and opens up the gateway for its further elaboration in orthogonal glycosylations.

Table 5 Glycosylatin reaction based on thioglycosidesa
Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β)
a All reactions were performed in dry DCM with 1.2 equiv. of donor 1 equiv. NIS and 20 mole% of FeCl3 at −5 °C to rt.b Isolated yield.
1 image file: c6ra21859h-u53.tif image file: c6ra21859h-u54.tif image file: c6ra21859h-u55.tif 88% β only
2 image file: c6ra21859h-u56.tif 59 image file: c6ra21859h-u57.tif 92% β only
3 image file: c6ra21859h-u58.tif 6 image file: c6ra21859h-u59.tif 94% β only
4 58 6 image file: c6ra21859h-u60.tif 89% β only
5 image file: c6ra21859h-u61.tif 4 image file: c6ra21859h-u62.tif 91% β only
6 image file: c6ra21859h-u63.tif image file: c6ra21859h-u64.tif image file: c6ra21859h-u65.tif 91% α only
7 image file: c6ra21859h-u66.tif image file: c6ra21859h-u67.tif image file: c6ra21859h-u68.tif 90% α only


Orthogonal glycosylation of trichloroacetimidate donors with thioglycosides pave the way for efficient streamline oligosaccharide assemblies.28 Activity of FeCl3 towards orthogonal glycosylation of trichloroacetimidate donors with thio glycoside acceptors have also been investigated there after (Table 6). Glycosylation with orthogonal trichloroacetimidate donor 1 and the glycosyl acceptor 74 bearing thiophenyl group at its anomeric position produced the corresponding β disaccharide 75 in 85% yield (entry 1, Table 6). Similar reaction between 2,3-di-O-benzyl-4,6-O-benzylidene-α-D-glucopyranosyl trichloroacetimidate donor 10 and phenyl 2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 74 generated the desired β disaccharide 76 in 94% yield (entry 2, Table 6). Coupling of trichloroacetimidate donors 77, 80 and 83 separately with the thioglycoside acceptors 78 (entry 3, Table 6), 81 (entry 4, Table 6) and 84 (entry 5, Table 6), respectively produced the corresponding glycosides 79, 82 and 85 in 94%, 92% and 88% yield. Unexpectedly, the armed fucosyl TCA donor 83 produced selectively the corresponding α-glycoside, 85. This could be due to much high reactivity of 83, for which here the glycosylation reaction probably proceeds via formation of the corresponding oxonium ion intermediate rather than via the corresponding Fe-chelated TS. This might cause the anomeric selectivity in favour of the thermodynamic product, α-glycoside (85). All the reactions under Tables 1–6 clearly represent the applicability of FeCl3 in stereoselective glycosylation via trichloroacetemidate activation, thioglycoside activation in combination with NIS and also orthogonal glycosylation of the former in the presence of the thioglycoside acceptor.

Table 6 Orthogonal glycosylationsa
Entry Donor Acceptor Product Yieldb[thin space (1/6-em)]:[thin space (1/6-em)]β)
a All reactions were performed in dry DCM with 1.2 equiv. of donor and 10 mole% of FeCl3 at −60 °C to rt.b Isolated yield.
1 1 image file: c6ra21859h-u69.tif image file: c6ra21859h-u70.tif 85% β
2 10 74 image file: c6ra21859h-u71.tif 94% β
3 image file: c6ra21859h-u72.tif image file: c6ra21859h-u73.tif image file: c6ra21859h-u74.tif 94% α
4 image file: c6ra21859h-u75.tif image file: c6ra21859h-u76.tif image file: c6ra21859h-u77.tif 92% α
5 image file: c6ra21859h-u78.tif image file: c6ra21859h-u79.tif image file: c6ra21859h-u80.tif 88% α


Now, finally the efficacy of FeCl3 was exemplified for chain elongation, essential for oligosaccharide synthesis29 by one pot sequential glycosylation with trichloroacetimidate donor followed by thioglycoside activation (Scheme 3).


image file: c6ra21859h-s3.tif
Scheme 3 Application in one-pot sequential glycosylation reaction.

For this trichloroacetimidate donor 1 was allowed to react with 4-methylphenyl 2,3,4-tri-O-benzoyl-1-thio-β-D-glucopyranoside 86 at −60 °C to room temperature in the presence of 10 mole% FeCl3; after consumption of both of the starting materials (checked by TLC) and after an increase of the reaction temperature to 0 °C the acceptor 8 was injected followed by addition of NIS along with additional 10 mole% FeCl3. The reaction was complete within 15 minutes giving the trisaccharide 39 in 87% yield as β anomer (Scheme 3).

So far we have observed that glucose and galactose based trichloroacetimidate armed donors are activated by FeCl3 generating selectively 1,2-trans glycosides in reaction with a variety of glycosyl acceptors (Tables 2, 4 and 6). It is also interesting to note that the reaction of β-TCA donor with 2 under similar condition also produced the same product 3 in comparable yield and selectivity (entry 11, Table 1). Moreover, in situ anomerisation of each of α- or β-TCA in the presence of FeCl3 in CH2Cl2 solution could not also be established. These facts preclude the possibility of these reactions to proceed following SN2 like pathway. All these thus support our initial proposition of the reaction proceeding via a SN1 type mechanistic pathway through probably an initial formation of a 7-membered chelate in each case of the α- and β-TCA donor. Whereas the former chelate is attacked from the β-side of the carbocation intermediate by the incoming glycosyl acceptor (α-side being blocked, Fig. 1), but, for the more reactive β-TCA probably there is sufficient time lag between breaking of the β-C1–O bond of the donor and formation of the β-glycosidic bond so that the approach of the incoming nucleophile can be accommodated at the β-side, since the α-side is still blocked by the bulky pendant C2–O–[Fe]NCOCCl3 group. In the case of mannosyl donor (entry 10, Table 2) possibility of chelation of catalyst with C-1 and C-2 substituents in the reactant donor does not arise due to their 1,2-trans diaxial orientation. So here probably the reaction proceeds via usual intermediate oxocarbenium ion.30 It has already been reported that with greater number of degrees of freedom, a direct steric interaction between the 6-benzyloxy group and the aglycon is possible, and this interaction will predominate the formation of α-anomer over the β one.31 Moreover, the bulk of benzyloxy group at 4-position also restricts the conformational space allotted for 3-O-benzyl ether, which in turn might impinge on the conformation of 2-O-benzyl ether destabilizing the β anomer over the α one.31

To corroborate with the above we further planned to perform FeCl3 mediated glycosylation reactions (Table 7) using two other armed donors. Like the armed trichloroacetimidate donor 1 bearing C-2–OBn (Table 1), the first trichloroacetimidate donor having a C-2–OMe group 87 (entry 1, Table 7) in reaction with the glycosyl acceptor 2, generated the corresponding disaccharide 88 (entry 1, Table 7) with exclusive 1,2-trans or β-anomeric selectivity. This observation precludes the take part of the phenyl ring of the 2-O-benzyl protection during formation of the proposed TS (b or c, Fig. 1). Additional indirect endorsement in favour of the projected mechanistic pathway (Fig. 1) came from a glycosylation reaction of acceptor 15 utilising 2-deoxy glycosyl donor 89 (entry 2, Table 7) which afforded the corresponding glycoside 90 in 87% yield but with α-anomeric selectivity, as evidenced by NMR32 (1H- and 13C-) spectra. In the absence of 2-oxygen formation of TS (b) or (c) (Fig. 1) does not arise here. With the deoxy donor the reaction probably proceeds via formation of the usual oxonium ion intermediate.

Table 7 Glycosylation reactions in support of anticipated mechanistic pathway
Entry Donor Acceptor Product Yielda α[thin space (1/6-em)]:[thin space (1/6-em)]β ratio
a Isolated yield.
1 image file: c6ra21859h-u81.tif 2 image file: c6ra21859h-u82.tif 93% 0[thin space (1/6-em)]:[thin space (1/6-em)]1
2 image file: c6ra21859h-u83.tif image file: c6ra21859h-u84.tif image file: c6ra21859h-u85.tif 87% 1[thin space (1/6-em)]:[thin space (1/6-em)]0


Conclusion

In summary, we have demonstrated an efficient general glycosylation reaction condition catalyzed by FeCl3 based on armed and disarmed trichloroacetimidate donors for the synthesis of 1,2-trans glycosides, and its use as a promoter in combination with NIS in thioglycoside activation. Advantages of this protocol include operational simplicity, general excellent yield, use of a catalytic amount of commercially available inexpensive, green catalyst for the activation of trichloroacetimidate, and formation of 1,2-trans glycoside in preparative scale (g) also. The applicability of this method to a broader scope of phenol nucleophiles as well as a wide variety of sugar nucleophiles and its excellent 1,2-trans selectivity both in the presence or absence of predesigned auxiliary protecting group. Its application in orthogonal glycosylation using trichloroacetimidate donor with thioglycoside acceptor, synthesis of a trisaccharide based on one-pot sequential glycosylation reactions, make this general protocol a promising one. We believe it will definitely find immense application in glyco-chemistry. Ramification of the present methodology including the orthogonal glycosylation leading to oligosaccharide synthesis are underway for future publication.

Experimental

General procedures

All reactions were performed in flamed-dried flasks fitted with rubber septa under a positive pressure of argon, unless otherwise stated. Dichloromethane was refluxed with P2O5 and distilled before use and stored over 4 Å molecular sieves. FeCl3 was purchased from (Merck, India). Traces of water in the donor and acceptor glycosides were removed by co-evaporation with toluene. Molecular sieves (4 Å) were flame dried before use. Flash column chromatography was performed employing silica gel 60 sorbent (40–63 μm, 230–400 mesh). Thin-layer chromatography (analytical and preparative) was performed using Merck silica gel plates (60-F254) to monitor the reactions and visualized under UV (254 nm) and/or by charring with 5% ethanolic solution of sulfuric acid. 1H and 13C NMR spectra were recorded on a Bruker DPX-300 (300 MHz), a Bruker DPX-400 (400 MHz), a Bruker DPX-500 (500 MHz), or a Bruker DPX-600 (600 MHz) spectrometer at ambient temperature in CDCl3, and assigned using 2D-methods (COSY, HSQC). Optical rotations were measured using Jasco P-1020 digital polarimeter. High Resolution Mass Spectra (HRMS) were measured in a QTOF I (quadrupole-hexapole-TOF) mass spectrometer with an orthogonal Z-spray-electrospray interface on micro (YA-263) mass spectrometer (Manchester, UK). All the known compounds were characterised by NMR spectroscopic analysis and comparing those with their previously reported literature values.

Materials

All glycosydic donors 1, 10, 12, 19, 21, 24, 27, 29, 32, 34, 36, 40, 58, 61, 63, 66, 68, 71, 77, 80, 83, 87, 89 and 91 acceptors 2, 4, 8, 15, 17, 22, 25, 30, 38, 41, 69, 72, 74, 78, 81, 84 and 86 were prepared according to standard literate procedures. Adamentanol (6), long chain alcohol (59) and arometic nucleophilic phenols 44, 46, 50, 53 and 55 were purchased at the highest possible purity from Alfa Aesar and Sigma-Aldrich and used as received.

General procedure for glycosylation with carbohydrate acceptors

A 10 mL oven-dried round bottom flask was charged with trichloroacetimidate donor (1.2 equiv.), glycosyl acceptor (1 equiv.), and CH2Cl2 (3 mL). The resulting solution was stirred on freshly dried 4 Å molecular sieves for 40 min at room temperature under argon atmosphere. Then this mixture was cooled to −60 °C, FeCl3 (0.1 equiv.) was added, and the reaction mass was allowed to achieve room temperature. After the acceptor was consumed completely (checked by TLC) molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude mass was purified by silica gel column chromatography and collected as pure product.

General procedure for glycosylation with phenol acceptors

A 10 mL oven-dried round bottom flask was charged with trichloroacetimidate donor (1.2 equiv.), phenol acceptor (1 equiv.), and CH2Cl2 (3 mL). The resulting solution was stirred on freshly dried 4 Å molecular sieves for 40 min at room temperature under argon atmosphere. Then this mixture was cooled to −5 °C, FeCl3 (0.1 equiv.) was added, and the reaction mass was allowed to achieve room temperature. After the acceptor was consumed completely (checked by TLC) molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude mass was purified by silica gel column chromatography (60–120 mesh) and collected as pure product.

General procedure for glycosylation with thioglycoside donors

To a mixture of thioglycoside donor (1.1 equiv.) and acceptor (1 equiv.) in dry CH2Cl2 (5 mL), flame activated molecular sieves (4 Å) were added. It was stirred at room temperature under argon atmosphere. After 40 min the mixture was cooled to −5 °C, and NIS (1 equiv.) was added to it. Then FeCl3 (0.2 equiv.) was added. After the acceptor was consumed completely (checked by TLC) reaction mixture was filtered off through Celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated sodium thio sulphate, NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude mass was purified by silica gel column chromatography (60–120 mesh).

Methyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (3)33

A 10 mL oven-dried round bottom flask was charged with 2,3,4,6-tetra-O-benzyl-D-glucopyranosyl trichloroacetimidate donor 1 (48.5 mg, 0.071 mmol, 1.2 equiv.), methyl 2,3,4-tri-O-benzoyl-α-D-glucopyranoside 2 (30 mg, 0.06 mmol, 1 equiv.), and CH2Cl2 (3 mL). The resulting solution was stirred on freshly dried 4 Å molecular sieves for 40 min at room temperature under argon atmosphere. Then this mixture was cooled to −60 °C, FeCl3 (1.2 mg, 0.007 mmol, 0.1 equiv.) was added, and the reaction mass was allowed to achieve room temperature. After the acceptor was consumed completely (checked by TLC) molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude mass was purified by silica gel column chromatography (60–120 mesh) and collected as colorless syrup (3, 59.38 mg, 96%).33

Scale-up (∼30 fold) experimental procedure for preparation of 3

The scale-up experiment was done following the above reaction procedure using 1 (1.47 g, 2.16 mmol), 2 (0.92 g, 1.8 mmol), 4 Å molecular sieves, FeCl3 (35 mg, 0.022 mmol) in dry CH2Cl2 (45 mL). Pure chromatographed product (3, 1.65 g) was obtained in 89% yield. Rf = 0.18 (hexane/ethyl acetate, 6/1); [α]20D +3.2 (c 0.8, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 3.31 (s, 3H, OCH3), 3.33–3.37 (m, 2H), 3.50–3.58 (m, 4H), 3.81 (dd, 1H, J = 8.5, 11.5 Hz), 4.00 (m, 2H), 4.35 (d, 1H, J = 12.0 Hz, BnH), 4.41–4.48 (m, 3H, BnH), 4.55 (d, 1H, J = 8.0 Hz, H1), 4.64–4.72 (m, 3H, BnH, H1), 4.83 (d, 1H, J = 11.0 Hz, BnH), 4.90 (d, 1H, J = 11.0 Hz, BnH), 5.32 (t, 1H, J = 9.5 Hz, H4), 5.39 (app t, 1H, J = 8.5, 9.0 Hz, H2), 5.79 (t, 1H, J = 9.5 Hz, H3), 7.06 (bd, 2H, J = 5.5 Hz, ArH), 7.16–7.34 (m, 25H, ArH) 7.42 (app t, 2H, J = 7.0, 7.5 Hz, ArH), 7.72 (d, 2H, J = 8.0 Hz, ArH), 7.84 (d, 2H, J = 7.5 Hz, ArH), 7.87 (d, 2H, J = 7.5 Hz, ArH). 13C NMR (CDCl3, 125 MHz): δ 57.1, 68.7, 68.8, 70.1, 71.9, 73.1, 73.5, 74.4, 74.7, 74.8, 74.9, 75.6, 76.6, 82.2, 101.9 (C1), 104.0 (C1), 127.6, 127.7, 127.8, 127.9, 128.2, 128.3, 128.9, 129.4, 129.7, 129.8, 133.2, 133.5, 138.2, 138.6, 165.12 (C[double bond, length as m-dash]O), 165.5 (C[double bond, length as m-dash]O), 165.8 (C[double bond, length as m-dash]O). HRMS (ESI-TOF): calculated for C62H60O14Na (M + Na) 1051.3881 found 1051.3882.

Methyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (5)33

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 5 in 93% β only as white solid,33 Rf 0.33 (80% CH2Cl2 in hexane); mp 84–85 °C (from hexane), lit.33 mp 88–89 °C, mp 79–81 °C (ether–hexane); [α]24D +22.8 (c 1.15, CHCl3); lit.33 [α]24D +22 (c 0.4 CHCl3); 1H NMR (CDCl3, 300 MHz): δ 3.34–3.38 (m, 2H), 3.41 (s, 3H, OCH3), 3.49–3.56 (m, 3H), 3.60–3.65 (m, 3H), 3.77 (bd, 1H, J = 10.9 Hz, BnH), 3.88–3.94 (m, 2H), 4.02 (t, 1H, J = 9.7 Hz), 4.41–4.48 (m, 4H, BnH), 4.59–4.68 (m, 4H, BnH), 4.77–4.95 (m, 7H, BnH, H1, H1), 5.14 (d, 1H, J = 11.3 Hz, BnH), 7.23–7.49 (m, 35H, ArH). 13C NMR (CDCl3, 75 MHz): δ 55.3, 67.9, 69.1, 70.1, 73.4, 73.7, 74.8, 74.9, 75.2, 75.4, 75.6, 78.1, 78.9, 80.4, 82.8, 84.9, 98.5 (C1), 102.5 (C1), 127.1, 127.3, 127.5, 127.6, 127.7, 127.8, 127.82, 128.02, 128.04, 128.08, 128.1, 128.3, 128.4, 128.5, 137.9, 138.3, 138.4, 138.6, 138.62, 138.7, 139.6. HRMS (ESI-TOF): calculated for C63H70O11Na (M + Na) 1025.4816 and found 1025.4814.

Adamentyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (7)19c

A mixture of 1 (75 mg, 0.11 mmol), 6 (14 mg, 0.088 mmol) and flame activated 4 Å molecular sieves were stirred in dry solvent (4 mL) for 40 min at room temperature under argon atmosphere. The mixture was cooled to −5 °C, and FeCl3 (1.8 mg, 0.011 mmol) was added to it. After the acceptor was consumed completely (checked by TLC) molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 7 (62.3 mg) in 94% β as white solid.19c Rf = 0.72 (hexane/ethyl acetate, 4/1). Mp 118–120 °C (from ethyl acetate, pet-ether), [α]24D +14.2 (c 0.96, CHCl3); 1H NMR (CDCl3, 300 MHz): δ 1.65 (bs, 6H), 1.83–1.93 (m, 6H), 2.17 (bs, 3H), 3.58 (dd, 1H, J = 3.6, 9.7 Hz), 3.60–3.72 (m, 2H), 3.80 (dd, 1H, J = 3.5, 10.5 Hz), 4.03–4.09 (m, 2H), 4.49 (d, 1H, J = 12.1 Hz, BnH), 4.51 (d, 1H, J = 9.6 Hz, BnH), 4.68 (t, 1H, J = 12.1 Hz, BnH), 4.73 (m, 2H, BnH), 4.83–4.89 (app t, 2H, J = 9.5, 10.5 Hz, BnH), 5.03 (d, 1H, J = 10.9 Hz, BnH), 5.32 (d, 1H, J = 3.5 Hz, H1), 7.17–7.38 (m, 20H, ArH). 13C NMR (CDCl3, 75 MHz): δ 30.7, 36.3, 42.5, 68.8, 69.7, 72.8, 73.4, 74.5, 75.1, 75.5, 78.2, 80.1, 82.1, 89.9 (C1), 127.5, 127.6, 127.7, 127.76, 127.8, 127.9, 128.0, 128.1, 128.3, 138.36, 138.1, 138.4, 138.42, 139.1. HRMS (ESI-TOF): calculated for C44H50O6 Na (M + Na) 697.3575, found 697.3507.

2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (9)19b

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 9 in 85% β as colorless syrup.19b Rf = 0.36 (hexane/ethyl acetate, 4/1); [α]22D −24 (c 1.0, CHCl3); 1H NMR (CDCl3, 300 MHz): δ 1.33 (s, 6H, CH3), 1.52 (s, 3H, CH3), 1.55 (s, 3H, CH3), 3.45–3.50 (m, 2H), 3.59–3.69 (m, 2H), 3.72–3.78 (m, 2H), 4.11 (m, 1H, H5), 4.18 (dd, 1H, J = 3.3, 10.5 Hz, H6), 4.26 (bd, 1H, J = 7.9 Hz, H4), 4.33 (dd, 1H, J = 2.0, 4.5 Hz, H2), 4.46–4.65 (m, 5H, BnH, H1, H3, H6), 4.71–4.84 (m, 4H, BnH), 4.97 (d, 1H, J = 10.9 Hz, BnH), 5.07 (d, 1H, J = 11.0 Hz, BnH), 5.58 (d, 1H, J = 4.9 Hz, H1), 7.14–7.44 (m, 20H, ArH). 13C NMR (CDCl3, 100 MHz): δ 24.5, 25.1, 26.1, 26.1, 67.4, 68.9, 69.8, 70.6, 70.9, 71.5, 73.6, 74.4, 74.9, 75.1, 75.7, 77.8, 81.7, 84.6, 96.5 (C1), 104.5 (C1), 108.6 (CMe2), 109.4 (CMe2), 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.3, 128.4, 128.7, 138.2, 138.8. HRMS (ESI-TOF): calculated for C46H54O11Na (M + Na) 805.3558 found 805.3559.

2,3-Di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranosyl-(1→6)-1,2:3,4-(di-O-isopropylidene)-α-D-galactopyranose (11)38

The crude residue was purified by silica gel column chromatography (60–120 mesh) and collected as colorless syrup (87%). Rf = 0.49 (hexane/ethyl acetate, 3/1); 1H NMR (CDCl3, 300 MHz) δ 1.33 (s, 6H, CH3), 1.46 (s, 3H, CH3), 1.51 (s, 3H, CH3), 3.40–3.50 (m, 2H), 3.63–3.81 (m, 4H), 4.08–4.13 (m, 2H), 4.24 (bd, 1H, J = 7.8 Hz, H4), 4.31–4.37 (m, 2H), 4.57–4.61 (m, 2H, H3, H1), 4.73–4.92 (m, 3H, BnH), 5.01 (d, 1H, J = 11.0 Hz, BnH), 5.56 (s, 1H, PhCH), 5.57 (d, 1H, J = 6.3 Hz, H1), 7.26–7.48 (m, 15H, ArH). 13C NMR (CDCl3, 75 MHz): δ 24.5, 24.9, 26.0, 26.1, 66.0, 67.2, 68.8, 70.0, 70.5, 70.8, 71.4, 74.8, 75.1, 77.2, 80.7, 81.4, 81.4, 81.6, 96.4 (C1), 101.1 (PhCH), 104.9 (C1), 108.6 (CMe2), 109.4 (CMe2), 126.0, 127.5, 128.0, 128.2, 128.3, 128.5, 128.9, 137.3, 138.6. HRMS (ESI-TOF): calculated for C38H43O11Na (M + Na) 698.2703 and found 698.2781.

Methyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (13)35

The crude mass was purified by silica gel column chromatography (60–120 mesh) and collected as colorless syrup (95%).35 Rf = 0.28 (hexane/ethyl acetate, 6/1); 1H NMR (CDCl3, 300 MHz): δ 3.38 (s, 3H, OCH3), 3.46–3.52 (m, 4H), 3.79–3.96 (m, 3H), 4.06–4.09 (m, 2H), 4.31–4.41 (m, 2H), 4.49 (d, 1H, J = 7.6 Hz, H1), 4.58–4.63 (m, 2H), 4.63–4.79 (m, 3H, BnH, H1), 4.92 (d, 1H, J = 11.7 Hz, BnH), 4.98 (d, 1H, J = 11.0 Hz, BnH), 5.38 (app t, 1H, J = 9.6, 9.9 Hz, H4), 5.47 (t, 1H, J = 9.6 Hz, H2), 5.87 (t, 1H, J = 9.6 Hz, H3), 7.24–7.40 (m, 27H, ArH), 7.47–7.51 (m, 2H, ArH), 7.80–7.83 (d, 2H, J = 7.1 Hz, ArH), 7.89–7.92 (d, 2H, J = 8.0 Hz, ArH), 7.96–7.98 (d, 2H, J = 6.6 Hz, ArH). 13C NMR (CDCl3, 125 MHz): δ 57.3, 68.7, 68.8, 70.2, 72.1, 73.1, 73.2, 73.4, 73.5, 73.56, 73.61, 74.5, 74.6, 75.1, 79.6, 82.1, 101.9 (C1), 104.3 (C1), 127.5, 127.6, 127.7, 127.8, 127.9, 128.1, 128.2, 128.3, 128.42, 128.48, 128.5, 128.9, 129.0, 129.8, 129.9, 133.2, 137.9, 129.5, 138.5, 138.7, 138.9, 165.3 (C[double bond, length as m-dash]O), 165.6 (C[double bond, length as m-dash]O), 165.9 (C[double bond, length as m-dash]O). HRMS (ESI-TOF): calculated for C62H60O14Na (M + Na) 1051.3881 found 1051.3880.

Methyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (14)34,36

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 14 in 88% β as white foam36 Rf = 0.52 (hexane/ethyl acetate, 3/1); 1H NMR (CDCl3, 300 MHz): δ 3.38–3.43 (m, 3H), 3.43 (s, 3H, OCH3), 3.51–3.68 (m, 4H), 3.77–4.00 (m, 5H), 4.29 (d, 1H, J = 11.8 Hz, BnH), 4.36–4.45 (m, 2H), 4.37 (d, 1H, J = 7.5 Hz, H1), 4.57–4.76 (m, 6H, BnH, H1), 4.80–4.90 (m, 4H), 5.03 (d, 1H, J = 11.4 Hz, BnH), 5.10 (d, 1H, J = 11.7 Hz, BnH), 7.19–7.44 (m, 35H, ArH). 13C NMR (CDCl3, 75 MHz): δ 55.3, 68.1, 68.3, 70.1, 72.6, 73.2, 73.5, 73.7, 73.8, 74.8, 75.3, 75.5, 77.3, 79.0, 80.1, 80.3, 82.5, 98.5 (C1), 102.9 (C1), 127.0, 127.3, 127.4, 127.5, 127.53, 127.6, 127.67, 127.7, 127.8, 127.9, 128.1, 128.16, 128.2, 128.3, 128.4, 138.2, 138.3, 138.6, 138.7, 139.0, 139.1, 139.5. HRMS (ESI-TOF): calculated for C62H66O11Na (M + Na) 1009.4501 found 1009.4503.

Methyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→3)-2-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (16)37

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 16 in 89% β as colorless syrup. Rf = 0.35 (hexane/ethyl acetate, 4.5/1); 1H NMR (CDCl3, 300 MHz): δ 3.35 (s, 3H, OCH3), 3.36–3.43 (m, 2H), 3.49 (dd, 1H, J = 2.6, 9.7 Hz), 3.59–3.72 (m, 4H), 3.76–3.88 (m, 3H), 4.19–4.37 (m, 4H), 4.46 (d, 1H, J = 3.7 Hz, H1), 4.52 (d, 1H, J = 12.1 Hz, BnH), 4.61 (d, 1H, J = 11.4 Hz, BnH), 4.70 (bs, 2H, BnH), 4.74–4.82 (m, 3H, BnH, H1), 4.94 (d, 1H, J = 11.6 Hz, BnH), 5.04 (d, 1H, J = 11.0 Hz, BnH), 5.51 (s, 1H, PhCH), 7.19–7.48 (m, 30H, ArH). 13C NMR (CDCl3, 125 MHz): δ 55.2, 63.2, 68.7, 70.2, 70.7, 73.3, 73.5, 73.6, 74.7, 75.0, 78.9, 79.5, 82.4, 98.2 (C1), 103.90 (C1), 103.91 (PhCH) 127.4, 127.7, 127.8, 127.9, 128.0, 128.04, 128.13, 1228.26, 128.39, 128.42, 128.50, 128.55, 129.1, 129.8, 134.5, 136.6, 137.8, 138.4, 138.5, 138.6, 139.0. HRMS (ESI-TOF): calculated for C55H58O11Na (M + Na) 917.3878 found 917.3877.

Methyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→2)-3-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (18)38

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 18 in 90% β as colorless syrup.38 Rf = 0.35 (hexane/ethyl acetate, 4.5/1); 1H NMR (CDCl3, 300 MHz): δ 3.45–3.47 (m, 6H, OCH3), 3.57–3.61 (m, 2H), 3.73–3.78 (m, 2H), 3.79–3.85 (m, 3H), 3.81 (d, 1H, J = 2.3 Hz), 4.36 (dd, 1H, J = 4.9, 10.4 Hz, H6), 4.42 (bs, 2H), 4.51 (d, 1H, J = 6.5 Hz, H1), 4.62 (d, 1H, J = 11.6 Hz, BnH), 4.67–4.76 (m, 4H, BnH), 4.80 (d, 1H, J = 4.8 Hz, H1), 4.83 (d, 1H, J = 7.9 Hz, BnH), 4.94 (d, 1H, J = 10.8 Hz, BnH), 4.95 (d, 1H, J = 11.6 Hz, BnH), 5.56 (s, 1H, PhCH), 7.16–7.38 (m, 30H, ArH). 13C NMR (CDCl3, 75 MHz): δ 56.7, 65.6, 68.7, 68.9, 72.9, 73.4, 73.5, 73.7, 74.6, 74.9, 75.1, 79.3, 79.9, 81.3, 81.5, 82.5, 101.1 (PhCH), 102.8 (C1), 103.4 (C1), 126.0, 127.3, 127.5, 127.6, 127.7, 127.8, 128.0, 128.1, 128.2, 128.23, 128.3, 128.37, 128.4, 128.9, 137.4, 137.9, 138.4, 138.5, 138.7, 138.9. HRMS (ESI-TOF): calculated for C55H58O11Na (M + Na) 917.3878, found 917.3877.

Methyl 2,3,4,6-tetra-O-benzyl-α-D-mannopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (20)22b

The crude mass was purified by silica gel column chromatography (60–120 mesh) and collected as colorless syrup (88%). Rf = 0.48 (hexane/ethyl acetate, 3/1); 1H NMR (CDCl3, 500 MHz): δ 3.32 (bs, 3H, OCH3), 3.45–3.50 (m, 2H), 3.58 (dd, 1H, J = 5.0, 11.0 Hz), 3.64–3.65 (m, 5H), 3.72–3.79 (m, 2H), 3.89 (t, 1H, J = 9.5 Hz), 4.13 (d, 1H, J = 12.0 Hz, BnH), 4.23 (d, 1H, J = 12.0 Hz, BnH), 4.34 (d, 1H, J = 12.5 Hz, BnH), 3.35 (d, 1H, J = 12.5 Hz, BnH), 4.42 (app t, 1H, J = 9.0, 11.0 Hz, BnH), 4.47–4.54 (m, 7H, BnH, H1), 4.60 (d, 1H, J = 12.0 Hz, BnH), 4.76 (d, 1H, J = 10.5 Hz, BnH), 5.01 (d, 1H, J = 11.5 Hz, BnH), 5.21 (d, 1H, J = 2.0 Hz, H1), 7.11–7.23 (m, 35H, ArH). 13C NMR (CDCl3, 125 MHz): δ 55.2, 69.3, 69.8, 72.0, 72.2, 72.9, 73.1, 73.2, 73.3, 74.8, 74.9, 75.0, 76.2, 77.7, 79.9, 81.5, 97.6 (C1), 100.5 (C1), 126.7, 127.1, 127.2, 127.3, 127.5, 127.6, 127.7, 127.96, 127.98, 128.0, 128.1, 128.25, 128.27, 128.34, 128.38, 128.4, 137.8, 138.3, 138.4, 138.6, 138.7, 138.8. HRMS (ESI-TOF): calculated for C63H70O11Na (M + Na) 1025.4816 and found 1025.4815.

Methyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-galactopyranosyl-(1→4)-2,3-O-isopropylidene-α-L-rhamnopyranoside (23)39

The crude residue was purified by silica gel column chromatography (60–120 mesh) and collected as white foam (92%). Rf = 0.49 (hexane/ethyl acetate, 3/1); [α]25D = +8.0 (c, 1.0, CHCl3); 1H NMR (CDCl3, 300 MHz) δ 1.33 (s, 3H, CH3), 1.37 (d, 3H, J = 5.5 Hz, CH3), 1.41 (s, 3H, CH3), 3.29 (bs, 1H, H2), 3.39 (s, 3H, OCH3), 3.58 (dd, 1H, J = 3.6, 9.7 Hz), 3.65–3.74 (m, 2H), 3.78 (m, 1H), 4.00 (bd, 1H, J = 12.1 Hz), 4.05–4.10 (m, 2H), 4.23–4.33 (m, 2H), 4.70–4.93 (m, 6H, BnH, H1, H1), 5.48 (s, 1H, PhCH), 7.26–7.56 (m, 15H, ArH). 13C NMR (CDCl3, 75 MHz): δ 17.9, 26.3, 27.8, 54.8, 66.3, 68.5, 69.2, 71.7, 73.5, 75.2, 76.2, 81.0, 98.1 (C1), 100.8 (C1), 101.3 (PhCH), 109.1 (CMe2), 126.1, 127.6, 127.9, 128.2, 128.5, 128.9, 137.4, 137.8, 137.9. HRMS (ESI-TOF): calculated for C37H44O10Na (M + Na) 671.2832 found 671.2861.

Methyl 2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl-(1→3)-2-O-benzoyl-4,6-O-benzylidene-α-D-glucopyranoside (26)22b

The crude residue was purified by column chromatography on silica gel (60–120 mesh) using PE/ethyl acetate 4[thin space (1/6-em)]:[thin space (1/6-em)]1 to afford 26 in 90% as white solid.22b Rf = 0.29 (25% ethyl acetate in hexane). [α]26D +28.2 (c 1.0, CHCl3); 1H (300 MHz, CDCl3): δ 1.72 (s, 3H, COCH3), 1.92 (s, 3H, COCH3), 2.04 (s, 3H, COCH3), 2.07 (s, 3H, COCH3), 3.41 (s, 3H, OCH3), 3.78–3.96 (m, 6H, H3, H4, H5, H5, H6, H6), 4.34 (dd, 1H, J = 3.9, 9.9 Hz, H6), 4.45 (app t, 1H, J = 9.2, 9.6 Hz, H6), 5.01 (d, 1H, J = 5.9 Hz, H1), 5.07–5.18 (m, 2H, H1, H4), 5.22 (dd, 1H, J = 3.7, 9.8 Hz, H3), 5.34–5.36 (m, 2H, H2, H2), 5.60 (s, 1H, CHPh), 7.27–7.60 (m, 8H, ArH), 8.08 (d, 2H, J = 6.5 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ 20.4, 20.6, 20.7, 55.5, 61.8, 62.1, 65.4, 68.3, 68.8, 69.0, 69.1, 71.7, 72.7, 77.4, 82.2, 97.8, 101.3 (PhCH), 126.0, 128.1, 128.5, 128.9, 129.4, 129.8, 133.5, 136.8, 165.5 (C[double bond, length as m-dash]O), 169.4 (C[double bond, length as m-dash]O), 169.6 (C[double bond, length as m-dash]O), 169.7 (C[double bond, length as m-dash]O), 170.6 (C[double bond, length as m-dash]O). HRMS (ESI-TOF): calculated for C35H40O16Na [M + Na]+ 716.2316, found 716.2317.

Methyl 2,3,4-tri-O-acetyl-α-L-rhamanopyranosyl-(1→3)-2-O-benzoyl-4,6-O-benzylidene-α-D-glucopyranoside (28)22b

The crude product was purified by silica gel (60–120 mesh) column chromatography (PE/ethyl acetate 5[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 28 in 89% as white solid.22b Rf = 0.38 (hexane/ethyl acetate, 4/1); mp 162–164 °C (from ethyl acetate–hexane); [α]25D +44 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ 0.75 (d, 3H, J = 6.2 Hz, CH3), 1.89 (s, 3H, COCH3), 1.91 (s, 3H, COCH3), 1.93 (s, 3H, COCH3), 3.38 (s, 3H, OCH3), 3.72 (t, 1H, J = 9.4 Hz), 3.82 (t, 1H, J = 10.2 Hz), 3.94 (dt, 1H, J = 4.6, 9.9 Hz, H5), 4.16 (m, 1H, H5), 4.34 (dd, 1H, J = 4.5, 10.0 Hz, H6), 4.42 (app t, 1H, J = 9.3, 11.6 Hz, H6), 4.89 (t, 1H, J = 10.0 Hz, H4), 5.00 (s, 1H, H1), 5.04–5.09 (m, 3H, H1, H2, H2), 5.22 (dd, 1H, J = 3.5, 10.0 Hz, H3), 5.59 (s, 1H, CHPh), 7.29–7.59 (m, 8H, ArH), 7.98–8.01 (m, 2H, ArH). 13C NMR (CDCl3, 75 MHz): δ 16.6, 20.4, 20.5, 20.6, 29.6, 55.4, 62.6, 66.2, 68.8, 68.9, 69.4, 70.9, 73.2, 74.7, 79.5, 97.7, 98.0, 101.9 (PhCH) 126.3, 128.0, 128.3, 129.1, 129.8, 133.3, 137.1, 165.6 (C[double bond, length as m-dash]O), 169.2 (C[double bond, length as m-dash]O), 169.8 (C[double bond, length as m-dash]O). HRMS (ESI-TOF): calculated for C33H38O14Na (M + Na) 658.2262 found 658.2261.

Methyl 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-mannopyranoside (31)22d

The crude residue was directly purified by silica gel flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 31 (91%) as a white foam.22d Rf = 0.28 (25% ethyl acetate in hexane). [α]26D +28.2 (c 1.0, CHCl3); 1H NMR (600 MHz, CDCl3): δ 2.01 (s, 3H, COCH3), 3.35 (s, 3H, OCH3), 3.43 (d, 1H, J = 10.8 Hz), 3.63 (dd, 1H, J = 3.0, 10.8 Hz), 3.70–3.77 (m, 5H), 3.84–3.85 (m, 3H), 4.16 (t, 1H, J = 9.0 Hz), 4.35 (d, 1H, J = 12.0 Hz), 4.41 (brs, 1H), 4.43 (brs, 1H), 4.53–4.58 (m, 3H), 4.60–4.65 (m, 4H), 4.67 (d, 1H, J = 10.8 Hz), 4.76 (s, 1H, H1), 4.80 (d, 1H, J = 10.8 Hz), 5.42 (brs, 1H, H1), 5.47 (brs, 1H), 7.13–7.34 (m, 30H, ArH). 13C NMR (150 MHz, CDCl3): δ 21.0, 54.9, 68.5, 68.6, 69.9, 71.4, 71.1, 71.7, 72.3, 72.5, 73.2, 73.4, 73.9, 74.0, 75.0, 78.4, 80.1, 98.7 (C1), 99.4 (C1), 127.3, 127.4, 127.45, 127.5, 127.57, 127.6, 127.7, 127.8, 127.9, 128.0, 128.2, 128.27, 128.3, 137.9, 138.1, 138.2, 138.3, 138.4, 138.5, 169.9 (C[double bond, length as m-dash]O); HRMS (ESI-TOF) : calculated for C57H62O12Na [M + Na]+ 961.4139 found 961.4131.

Methyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-mannopyranoside (33)

The crude product was purified by silica gel flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 33 (91%) as a white foam. Rf = 0.21 (25% ethyl acetate in hexane). [α]26D +59.5 (c 1.06, CHCl3); 1H NMR (600 MHz, CDCl3): δ 3.25 (s, 3H, OCH3), 3.39 (d, 1H, J = 9.6 Hz), 3.60–3.64 (m, 2H), 3.76 (t, 1H, J = 2.4 Hz), 3.90 (d, 1H, J = 3.0 Hz), 3.94 (t, 1H, J = 6.6 Hz), 4.26 (dd, 1H, J = 8.0, 12.0 Hz), 4.37 (apparent t, 2H, J = 9.0, 9.6 Hz), 4.40 (apparent t, 2H, J = 4.8, 6.0 Hz), 4.61 (d, 1H, J = 12.0 Hz), 4.67–4.73 (m, 3H, H1), 4.92 (d, 1H, J = 12.0 Hz), 4.99 (d, 1H, J = 8.4 Hz, H1), 5.40 (dd, 1H, J = 3.6, 10.8 Hz), 5.72 (dd, 1H, J = 8.4, 10.2 Hz), 5.87 (d, 1H, J = 3.6 Hz), 7.17–7.57 (m, 27H, ArH), 7.76 (d, 2H, J = 7.2 Hz, ArH), 7.89 (d, 2H, J = 7.8 Hz, ArH), 7.94 (d, 2H, J = 7.8 Hz, ArH), 7.97 (d, 2H, J = 7.2 Hz, ArH). 13C NMR (150 MHz, CDCl3): δ 54.9, 61.8, 68.8, 70.7, 71.2, 72.1, 72.7, 73.0, 73.5, 75.6, 78.5, 99.5 (C1) 101.2 (C1), 127.0, 127.4, 127.6, 127.9, 128.0, 128.4, 128.5, 128.6, 128.7, 129.0, 129.3, 129.4, 129.7, 129.9, 130.0, 133.26, 133.30, 133.4, 133.5, 138.6, 139.3, 165.3 (C[double bond, length as m-dash]O), 165.6 (C[double bond, length as m-dash]O), 165.7 (C[double bond, length as m-dash]O), 166.0 (C[double bond, length as m-dash]O). HRMS (ESI-TOF): calculated for C62H58O15Na [M + Na]+ 1065.3673, found 1065.3665.

Methyl 2,3-di-O-benzoyl-4,6-O-benzylidene-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (35)22b

The crude mass was purified by silica gel column chromatography (60–120 mesh) (PE/EtOAc 5[thin space (1/6-em)]:[thin space (1/6-em)]1) to get pure product 35 in 88% yield. It was crystallized from PE/EtOAc; mp 232–234 °C. [α]25D +38.8 (c 1.39, CHCl3). 1H NMR (CDCl3, 300 MHz): δ 3.12 (s, 3H, OCH3), 3.66–3.83 (m, 3H), 3.90 (app t, 1H, J = 9.4, 9.7 Hz), 4.08 (bd, 1H, J = 10.9 Hz), 4.21 (app t, 1H, J = 8.0, 9.3 Hz, H6), 4.42 (dd, 1H, J = 4.6, 10.2 Hz, H6), 4.91 (d, 1H, J = 4.1 Hz, H1), 4.93 (d, 1H, J = 7.3 Hz, H1), 5.11 (dd, 1H, J = 3.3, 10.2 Hz, H2), 5.33 (ABq, 1H, J = 9.7 Hz, H3), 5.48–5.58 (m, 2H, CHPh, H2), 5.81 (t, 1H, J = 9.5 Hz, H3), 6.08 (t, 1H, J = 9.8 Hz, H4), 7.27–7.50 (m, 20H, ArH), 7.90 (d, 2H, J = 8.5 Hz, ArH), 7.89–7.99 (m, 8H, ArH). 13C NMR (75 MHz, CDCl3): δ 55.0, 66.6, 68.5, 68.6, 69.6, 70.3, 71.9, 72.0, 72.4, 78.7, 96.4 (C1), 101.4 (PhCH), 102.0 (C1) 126.1, 128.19, 128.16, 128.26, 128.29, 128.33, 128.4, 129.0, 129.3, 129.6, 129.77, 129.84, 133.0, 133.1, 133.2, 133.4, 136.7, 165.3 (C[double bond, length as m-dash]O), 165.4 (C[double bond, length as m-dash]O), 165.6 (C[double bond, length as m-dash]O), 165.7 (C[double bond, length as m-dash]O). HRMS m/z calculated for (C55H48O16Na+) [M + Na]+ 987.2840, found: 987.2841.

Methyl 2-O-acetyl-3-O-benzyl-4,6-O-benzylidene-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (37)22d

The crude residue was purified by silica gel flash column chromatography (hexane/EtOAc, 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 37 (90%) as a white solid. Rf 0.30 (25% EtOAc in hexane); mp 185–186 °C (from PE–ethyl acetate); [α]26D +29.6 (c 1.0, CHCl3); 1H NMR (300 MHz, CDCl3): δ 2.07 (s, 3H, COCH3), 3.42 (m, 1H), 3.46 (s, 3H, OCH3), 3.68 (dd, 1H, J = 6.7, 10.8 Hz), 3.71–3.77 (m, 3H), 4.05 (dd, 1H J = 1.5, 10.8 Hz), 4.25 (m, 1H), 4.31 (dd, 1H, J = 4.9, 10.5 Hz), 4.54 (d, 1H, J = 7.9 Hz, H′1), 4.69 (d, 1H, J = 12.1 Hz, BnH), 4.88 (d, 1H, J = 12.1 Hz, BnH), 5.08 (dt, 1H, J = 2.4, 7.6 Hz, H′1), 5.23–5.27 (m, 2H, H1, H2), 5.45 (t, 1H, J = 9.8 Hz, H3), 5.55 (s, 1H, PhCH), 6.15 (t, 1H, J = 9.3 Hz, H4), 7.26–7.31 (m, 7H, ArH), 7.35–7.42 (m, 8H, ArH), 7.49–7.54 (m, 4H, ArH), 7.85–7.88 (m, 2H, ArH), 7.94–7.99 (m, 4H, ArH). 13C NMR (75 MHz, CDCl3): δ 20.9, 55.4, 66.2, 68.3, 68.5, 69.4, 70.5, 72.0, 72.6, 74.1, 78.4, 81.4, 96.7, 101.2 (C1), (PhCH), 101.8 (C1), 126.0, 127.6, 127.8, 128.2, 128.3, 128.40, 128.43, 128.87, 128.99, 129.03, 129.6, 129.8, 129.9, 133.0, 133.3, 133.5, 137.1, 138.2, 165.3 (C[double bond, length as m-dash]O), 165.7 (C[double bond, length as m-dash]O), 165.8 (C[double bond, length as m-dash]O), 169.4 (C[double bond, length as m-dash]O); HRMS (ESI-TOF) calculated for C50H48O15Na [M + Na]+ 911.2891, found 911.2889.

2,3,4,6-Tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-β-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (39)19c

The crude residue was purified by silica gel flash column chromatography (hexane/EtOAc, 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 39 (89%) as a white foam. Rf 0.30 (20% EtOAc in hexane); 1H NMR (CDCl3, 300 MHz): δ 1.33 (s, 4H), 1.69 (s, 8H), 3.43 (d, 2H, J = 3.43 Hz), 3.54–3.66 (m, 5H), 3.75–3.87 (m, 4H), 3.94–4.01 (m, 2H), 4.05–4.19 (m, 3H), 4.36 (m, 1H), 4.41–4.54 (m, 2H), 4.91 (d, 1H, J = 8.3 Hz), 4.59 (m, 1H), 4.66–4.84 (m, 3H), 4.91 (d, 1H, J = 8.3 Hz, H′′1), 5.38 (m, 1H), 5.44–5.53 (m, 2H), 5.87 (t, 1H, J = 9.5 Hz), 7.15–7.49 (m, 29H, ArH), 7.81 (d, 2H, J = 7.7 Hz, ArH), 7.92 (d, 2H, J = 7.4 Hz, ArH), 7.97 (d, 2H, J = 7.5 Hz, ArH). 13C NMR (CDCl3, 75 MHz): δ 24.1, 24.8, 25.7, 25.9, 67.4, 68.6, 68.7, 68.8, 70.3, 70.4, 70.5, 70.8, 71.8, 73.2, 73.5, 74.0, 74.7, 74.8, 74.9, 75.6, 77.7, 82.1, 84.6, 96.1 (C1), 101.3 (C′′1), 103.9 (C1), 108.3 (CMe2), 109.2 (CMe2), 127.5, 127.6, 127.7, 127.8, 127.91, 127.97, 128.15, 128.19, 128.24, 128.3, 128.4, 128.5, 128.7, 128.9, 129.7, 129.8, 130.0, 132.9, 133.1, 133.3, 133.4, 138.0, 138.2, 138.7, 165.2 (C[double bond, length as m-dash]O), 165.4 (C[double bond, length as m-dash]O), 165.8 (C[double bond, length as m-dash]O); HRMS (ESI): calculated for C73H76O19Na (M + Na) 1279.4879 found 1279.4870.

Methyl 3,4,6-tri-O-acetyl-2-deoxy-2-phathalimido-β-D-glucopyranosyl-(1→4)-[3,4,6-tri-O-acetyl-2-deoxy-2-phathalimido-β-D-glucopyranosyl-(1→6)]-2,3-di-O-benzyl-α-D-glucopyranoside (42)22d

The crude residue was purified by silica gel flash column chromatography (hexane/EtOAc, 1[thin space (1/6-em)]:[thin space (1/6-em)]2) to afford 42 (83%) as a white foam. Rf 0.31 (60% EtOAc in hexane). [α]24D +24.6 (c 1.0, CHCl3); lit.22d [α]20D +23.9 (c 0.8, CHCl3); 1H NMR (500 MHz, CDCl3): δ 1.80 (s, 3H, COCH3), 1.84 (s, 3H, COCH3), 1.97 (s, 3H, COCH3), 2.03 (s, 3H, COCH3), 1.99 (s, 3H, COCH3), 2.12 (s, 3H, COCH3), 3.06 (s, 3H, OCH3), 3.17–3.19 (m, 2H), 3.40 (app t, 1H, J = 9.0, 10.0 Hz), 3.52–3.59 (m, 2H), 3.66–3.68 (m, 2H), 3.76 (app t, 1H, J = 8.5, 9.5 Hz), 3.84 (dd, 1H, J = 2.5, 12.5 Hz), 4.08 (dd, 1H, J = 4.0, 12.5 Hz), 4.11–4.20 (m, 4H), 4.34 (dd, 1H, J = 5.0, 12.5 Hz), 4.41 and 4.53 (d, each 1H, J = 12.0 Hz, BnH), 4.82 and 4.90 (d, J = 12.0 Hz, each 1H, BnH), 5.05–5.12 (m, 3H), 5.47 (d, 1H, J = 8.5 Hz), 5.52 (dd, 1H, J = 9.5, 10.5 Hz), 5.69 (dd, 1H, J = 9.5, 10.5 Hz), 7.15–7.16 (m, 2H, ArH), 7.21–7.26 (m, 4H, ArH), 7.32–7.33 (m, 4H, ArH), 7.65–7.67 (m, 2H, ArH), 7.75–7.79 (m, 4H, ArH), 7.87–7.88 (m, 2H, ArH). 13C NMR (125 MHz, CDCl3): δ 20.4, 20.5, 20.7, 20.8, 20.9, 54.58, 55.0, 55.4, 61.8, 62.2, 68.7, 68.8, 69.2, 69.3, 70.8, 70.85, 71.8, 73.3, 74.5, 77.3, 79.5, 79.8, 97.5, 97.6, 99.0, 123.5, 123.9, 126.8, 127.2, 127.9, 128.0, 128.3, 128.4, 131.4, 131.7, 134.2, 134.7, 138.1, 139.5, 169.5 (C[double bond, length as m-dash]O), 170.2 (C[double bond, length as m-dash]O), 170.8 (C[double bond, length as m-dash]O), 170.9 (C[double bond, length as m-dash]O). HRMS (ESI-TOF) calcd for C50H48O15Na [M + Na]+ 911.2891, found 911.2889.

Methyl 2,3,4-tri-O-acetyl-α-L-rhamanopyranosyl-(1→4)-[2,3,4-tri-O-acetyl-α-L-rhamanopyranosyl-(1→6)]-2,3-di-O-benzyl-α-D-glucopyranoside (43)22b

The crude product was purified by flash column chromatography on silica gel (230–400 mesh) using PE/EtOAc 2[thin space (1/6-em)]:[thin space (1/6-em)]1 to afford 43 in 81% as white foam. 1H NMR (300 MHz, CDCl3): δ 0.79 (d, 3H, J = 6.2 Hz, CH3), 1.20 (d, 3H, J = 6.2 Hz, CH3), 1.97 (s, 3H, COCH3), 1.98 (s, 3H, COCH3), 1.99 (s, 3H, COCH3), 2.04 (s, 3H, COCH3), 2.09 (s, 3H, COCH3), 2.12 (s, 3H, COCH3), 3.39 (s, 3H, OCH3), 3.60 (dd, 1H, J = 3.6, 9.4 Hz), 3.65–3.78 (m, 4H), 3.83–3.95 (m, 3H), 4.00 (m, 1H), 4.57 (d, 1H, J = 3.5 Hz, H1), 4.59 (d, 1H, J = 12.0 Hz, BnH), 4.62 (d, 1H, J = 12.0 Hz, BnH), 4.72 (app t, 1H, J = 5.1, 5.7 Hz), 4.74 (d, 1H, J = 11.9 Hz, BnH), 4.80 (d, 1H, J = 1.5 Hz, H1/H′′1), 4.88 (d, 1H, J = 1.5 Hz, H′′1/H1), 4.97 (d, 1H, J = 10.1 Hz, BnH), 4.99–5.0 (m, 1H), 5.08 (d, 1H, J = 11.2 Hz, BnH), 5.13 (dd, 1H, J = 1.7, 3.5 Hz), 5.22 (dd, 1H, J = 3.5, 10.2 Hz), 5.27 (dd, 1H, J = 3.6, 6.5 Hz), 7.25–7.39 (m, 10H, ArH).

2′-Napthyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (45)40

A mixture of 1 (57 mg, 0.083 mmol), 44 (10 mg, 0.07 mmol) and flame activated 4 Å molecular sieves were stirred in dry solvent (4 mL) for 40 min at room temperature under argon atmosphere. The mixture was cooled to −5 °C and FeCl3 (1.3 mg, 0.0083 mmol) was added to it. After the acceptor was consumed completely (checked by TLC) molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude residue was directly purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 8[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 45 (44.86 mg) in 97% β as white foam.40 Rf = 0.42 (hexane/ethyl acetate, 4/1); 1H (300 MHz, CDCl3): δ 3.72–3.86 (m, 6H), 4.52–4.62 (m, 3H, BnH), 4.82–4.89 (m, 3H, BnH), 4.97 (d, 1H, J = 10.8 Hz, BnH), 5.11 (d, 1H, J = 10.8 Hz, BnH), 5.16 (d, 1H, J = 6.7 Hz, H1), 7.23–7.45 (m, 24H, ArH), 7.66 (d, 1H, J = 7.7 Hz, ArH), 7.76–7.80 (m, 2H, ArH).

4′-Methoxyphenyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (47)41

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9.5[thin space (1/6-em)]:[thin space (1/6-em)]0.5) to afford the compound 47 in 97% β as white solid.41 Rf = 0.54 (hexane/ethyl acetate, 9/1); 1H NMR (CDCl3, 500 MHz): δ 3.60 (m, 1H), 3.68–3.76 (m, 4H), 3.80 (s, 3H, OCH3), 3.83 (dd, 1H, J = 1.0, 10.0 Hz), 4.55–4.64 (m, 3H, BnH, H1), 4.84–4.93 (m, 4H, BnH), 4.98 (d, 1H, J = 11.0 Hz, BnH), 5.08 (d, 1H, J = 11.0 Hz, BnH), 6.84 (d, 2H, J = 9.0 Hz, ArH), 7.06 (d, 2H, J = 12.5 Hz, ArH), 7.22 (d, 2H, J = 10.0 Hz, ArH), 7.27–7.38 (m, 18H, ArH). 13C NMR (CDCl3, 75 MHz): δ 55.8, 69.1, 73.6, 75.1, 75.2, 75.9, 76.7, 77.9, 82.2, 84.8, 102.9 (C1) 114.7, 118.6, 127.7, 127.7, 127.8, 127.8, 127.9, 128.0, 128.1, 128.2, 128.3, 128.4, 128.5, 138.2, 138.3, 138.4, 138.7, 151.7, 155.4. HRMS (ESI-TOF): calculated for C41H42O7 Na (M + Na) 669.2823 found 669.2841.

2′,6′-Dimethylphenyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (49)40

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9.5[thin space (1/6-em)]:[thin space (1/6-em)]0.5) to afford the compound 49 in 90% β as white solid.40 Rf = 0.52 (hexane/ethyl acetate, 9/1); [α]27D +96.4 (c 1, CHCl3); 1H NMR (CDCl3, 400 MHz): δ 2.39 (s, 6H, 2 × CH3), 3.32 (m, 1H, H5), 3.65–3.77 (m, 5H), 4.46 (d, 1H, J = 12.4 Hz, BnH), 4.54 (d, 1H, J = 12.0 Hz, BnH), 4.62 (d, 1H, J = 10.8 Hz, BnH), 4.79–4.89 (m, 4H, BnH, H1), 5.01 (d, 1H, J = 10.8 Hz, BnH), 5.16 (d, 1H, J = 10.8 Hz, BnH), 6.98–7.04 (m, 3H, ArH), 7.20 (d, 1H, J = 1.2 Hz, ArH), 7.21 (d, 1H, J = 2.0 Hz, ArH), 7.25–7.33 (m, 16H, ArH), 7.38–7.40 (m, 2H, ArH). 13C NMR (CDCl3, 125 MHz): δ 17.3, 69.1, 73.6, 75.10, 75.17, 75.4, 75.8, 78.0, 83.0, 84.9, 104.3 (C1) 124.6, 127.5, 127.6, 127.7, 127.8, 128.1, 128.2, 128.3, 128.4, 128.5, 128.9, 132.0, 138.3, 138.4, 138.8, 153.4. HRMS (ESI-TOF): calculated for C42H44O6Na (M + Na) 667.3729, found 667.3731.

4′-Bromophenyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside (51)41

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9.5[thin space (1/6-em)]:[thin space (1/6-em)]0.5) to afford the compound 51 in 92% β as white solid.41 Rf = 0.54 (hexane/ethyl acetate, 9/1); 1H NMR (CDCl3, 500 MHz): 3.59–3.79 (m, 6H), 4.52 (d, 1H, J = 12.5 Hz, BnH), 4.56–4.60 (m, 2H, BnH), 4.82–4.87 (m, 3H, BnH), 4.94–4.98 (m, 2H, BnH, H1), 5.00 (d, 1H, J = 11.0 Hz, BnH), 6.95–6.97 (d, 2H, J = 8.5 Hz, ArH), 7.19–7.39 (m, 22H, ArH). 13C NMR (CDCl3, 75 MHz): δ 68.8, 73.5, 75.1, 75.3, 75.8, 77.7, 81.9, 84.7, 101.7 (C1) 127.8, 127.9, 128.0, 128.2, 128.4, 128.5, 132.4, 137.9, 138.1, 138.2, 138.5, 156.5.

2′-Napthyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside (52)40

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 8[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 52 in 97% β as white foam.40 Rf = 0.42 (hexane/ethyl acetate, 4/1); 1H (300 MHz, CDCl3): δ 3.60–3.71 (m, 3H), 3.77 (t, 1H, J = 5.9 Hz), 3.98 (d, 1H, J = 2.4 Hz), 4.19 (app t, 1H, J = 8.0 Hz), 4.45 (ABq, 2H, J = 11.6 Hz, BnH), 4.66 (d, 1H, J = 11.6 Hz, BnH), 4.76 (d, 1H, J = 11.9 Hz, BnH), 4.81 (d, 1H, J = 11.9 Hz, BnH), 4.89 (d, 1H, J = 11.8 Hz, BnH), 4.98–5.06 (app t, 2H, J = 11.3, 13.2 Hz, BnH), 5.14 (d, 1H, J = 7.6 Hz, H1), 7.26–7.37 (m, 22H, ArH), 7.42 (d, 2H, J = 2.4 Hz, ArH), 7.64 (d, 1H, J = 7.9 Hz, ArH), 7.33–7.79 (m, 2H, ArH).

1′-Napthyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside (54)40

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford compound 54 in 95% β as white foam.40 Rf = 0.62 (hexane/ethyl acetate, 4/1); 1H (300 MHz, CDCl3): δ 3.61–3.69 (m, 2H), 3.71–3.78 (m, 2H), 4.00 (d, 1H, J = 2.3 Hz), 4.32 (app t, 1H, J = 7.8, 9.4 Hz), 4.40 (d, 1H, J = 11.6 Hz, BnH), 4.47 (d, 1H, J = 11.7 Hz, BnH), 4.69 (d, 1H, J = 11.6 Hz, BnH), 4.79 (s, 2H, BnH), 4.97 (d, 1H, J = 10.6 Hz, BnH), 5.02 (d, 1H, J = 11.6 Hz, BnH), 5.12 (d, 1H, J = 10.6 Hz, BnH), 5.19 (d, 1H, J = 7.7 Hz, H1), 7.13 (d, 1H, J = 7.6 Hz, ArH), 7.23–7.41 (m, 22H, ArH), 7.46 (d, 1H, J = 8.4 Hz, ArH), 7.52 (d, 1H, J = 8.2 Hz, ArH), 7.80 (d, 1H, J = 7.7 Hz, ArH), 8.32 (d, 1H, J = 8.1 Hz, ArH).

4′-Chloro-3′-methylphenyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside (56)

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 56 in 94% β as white solid. Rf = 0.62 (hexane/ethyl acetate, 4/1); [α]25D −20.84 (c 1.9, CHCl3); 1H (300 MHz, CDCl3): δ 2.28 (s, 3H, CH3), 3.59–3.67 (m, 4H), 3.94 (bd, 1H, J = 2.6 Hz), 4.09 (dd, 1H, J = 7.8, 9.5 Hz), 4.37–4.48 (2d, 2H, J = 11.0 Hz, BnH), 4.63 (d, 1H, J = 11.6 Hz, BnH), 4.71–4.80 (2d, 2H, J = 11.0 Hz, BnH), 4.85 (d, 1H, J = 10.9 Hz, BnH), 4.91 (d, 1H, J = 7.7 Hz, H1), 4.96 (d, 1H, J = 10.8 Hz, BnH), 4.98 (d, 1H, J = 11.6 Hz, BnH), 6.83–7.36 (m, 23H, ArH). 13C NMR (CDCl3, 125 MHz): δ 20.4, 69.1, 73.3, 73.5, 73.8, 74.1, 74.7, 75.6, 79.3, 82.2, 102.3 (C1), 115.9, 119.7, 127.72, 127.78, 127.8, 127.9, 127.98, 128.3, 128.4, 128.5, 128.6, 129.7, 137.1, 137.9, 138.5, 138.6, 156.1. HRMS (ESI): calculated for C41H41ClO6Na (M + Na) 664.2592, found 664.2491.

2′,6′-Dimethylphenyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranoside (57)41

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 9.5[thin space (1/6-em)]:[thin space (1/6-em)]0.5) to afford the compound 57 in 91% β as white solid.41 Rf = 0.52 (hexane/ethyl acetate, 9/1); 1H NMR (CDCl3, 300 MHz): δ 2.35 (s, 6H, 2 × CH3), 3.41–3.52 (m, 2H), 3.57–3.65 (m, 2H), 3.93 (bd, 1H, J = 2.5 Hz), 4.11 (dd, 1H, J = 7.7, 9.7 Hz), 4.35 (bs, 2H, BnH), 4.64 (d, 1H, J = 11.7 Hz, BnH), 4.72–4.82 (m, 3H, BnH, H1), 4.89 (d, 1H, J = 10.9 Hz, BnH), 5.00 (d, 1H, J = 11.7 Hz, BnH), 5.10 (d, 1H, J = 10.9 Hz, BnH), 6.93–7.02 (m, 2H, ArH), 7.16–7.19 (m, 2H, ArH), 7.26–7.29 (m, 19H, ArH).

3-(N-Benzyloxycarbonyl)propyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (60)22b

The crude product was purified by column chromatography on silica gel (60–120 mesh) using PE/EtOAc 6[thin space (1/6-em)]:[thin space (1/6-em)]1 to give 60 in 88% as white foam; [α]25D +60.05 (c 1.28, CHCl3); 1H NMR (CDCl3, 500 MHz): δ 1.77–1.88 (m, 2H, CH2), 3.15–3.27 (m, 2H, NCH2), 3.67 (m, 1H, OCH), 4.03 (m, 1H, H5), 4.32 (t, 1H, J = 6.5 Hz, OCH), 4.42 (dd, 1H, J = 6.8, 11.8 Hz, H6), 4.67 (dd, 1H, J = 6.5, 11.5 Hz, H6), 4.81 (d, 1H, J = 7.5 Hz, H1), 5.00 (m, 1H, NH), 5.05 (s, 2H, BnH), 5.62 (dd, 1H, J = 3.8, 10.3 Hz, H3), 5.78 (dd, 1H, J = 8.3, 10.3 Hz, H2), 5.99 (d, 1H, J = 3.5 Hz, H4), 7.21–7.26 (m, 2H, ArH), 7.29 (m, 1H, ArH), 7.33–7.36 (m, 6H, ArH), 7.41–7.44 (m, 3H, ArH), 7.46–7.51 (m, 3H, ArH), 7.55 (t, 1H, J = 7.5 Hz, ArH), 7.62 (t, 1H, J = 7.5 Hz, ArH), 7.77–7.79 (d, 2H, J = 8.0 Hz, ArH), 7.94–7.95 (d, 2H, J = 8.0 Hz, ArH), 8.00–8.02 (m, 2H, ArH), 8.08–8.09 (d, 2H, J = 8.0 Hz, ArH); 13C NMR (125 MHz, CDCl3): δ 29.7, 38.3, 62.2, 66.6, 68.3, 70.0, 71.6, 71.7, 101.8 (C1), 128.1, 128.4, 128.6, 128.8, 128.9, 129.2, 129.4, 129.6, 129.8, 129.9, 130.2, 133.4, 133.5, 133.7, 156.6 (C[double bond, length as m-dash]O), 165.7 (C[double bond, length as m-dash]O), 166.2 (C[double bond, length as m-dash]O); HRMS m/z calcd for C45H41NO12Na+ calcd: 810.2527, found: 810.2526.

3-(N-Benzyloxycarbonyl)propyl 2,3,4,6-tetra-O-benzyl-β-D-galactopyranosyl-(1→4) 2-O-acetyl-3,6-di-O-benzyl-β-D-glucopyranoside (62)22e

The crude mass was purified by silica gel column chromatography (60–120 mesh) (PE/EtOAc 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to get pure product (62) as colourless syrup in 92% yield. [α]29D −2.57 (c 7.0, CHCl3); 1H NMR (500 MHz, CDCl3): δ 1.68–1.76 (m, 2H, CH2), 1.97 (s, 3H, COCH3), 3.23 (m, 1H, NCH), 3.33–3.37 (m, 3H), 3.38–3.43 (m, 2H), 3.46 (m, 1H), 3.55–3.59 (m, 2H), 3.69 (d, 1H, J = 10.0 Hz), 3.74–3.77 (m, 2H), 3.85 (m, 1H), 3.9 (d, 1H, J = 2.5 Hz), 3.95 (t, 1H, J = 9.0 Hz), 4.23 (d, 1H, J = 12.0 Hz), 4.29–4.34 (app t, 2H, J = 10.5, 11.5 Hz), 4.36–4.38 (dd, 2H, J = 1.5, 9.0 Hz), 4.48 (d, 1H, J = 12.0 Hz, BnH), 4.54 (d, 1H, J = 11.0 Hz, BnH), 4.58 (d, 1H, J = 11.0 Hz, BnH), 4.68 (d, 1H, J = 12.0 Hz, BnH), 4.72 (d, 1H, J = 12.0 Hz, BnH), 4.75 (d, 1H, J = 11.0 Hz, BnH), 4.82 (d, 1H, J = 11.0 Hz, BnH), 4.94–4.98 (m, 3H, H1, H1, H2), 5.08 (bs, 2H, BnH), 5.29 (bs, 1H, NH), 7.19–7.36 (m, 35H, ArH). 13C NMR (75 MHz, CDCl3): δ 20.9, 29.5, 38.2, 66.5, 66.7, 68.1, 68.3, 72.5, 72.6, 73.1, 73.5, 73.7, 74.3, 74.7, 75.3, 79.9, 80.8, 82.5, 100.8 (C1), 102.9 (C1), 127.2, 127.4, 127.5, 127.57, 127.62, 127.7, 127.9, 128.0, 128.1, 128.2, 128.3, 128.3, 128.4, 128.5, 136.9, 138.1, 128.2, 138.5, 138.8, 139.0, 139.1, 156.6 (C[double bond, length as m-dash]O), 169.6 (C[double bond, length as m-dash]O). HRMS (TOF): calc. for (M + Na)+ C67H73NO14Na 1138.4929, found 1138.4932.

Adamentyl 2,3,4,6-tetra-O-benzoyl-β-D-glucopyranoside (64)42

The crude mass was purified by silica gel column chromatography (60–120 mesh) (PE/EtOAc 5[thin space (1/6-em)]:[thin space (1/6-em)]1) to get pure product (64) as colourless syrup in 94% yield. 1H NMR (CDCl3, 300 MHz): δ 1.49–1.61 (m, 6H), 1.66–1.70 (m, 3H), 1.83–1.87 (m, 3H), 2.04 (s, 3H), 4.22 (m, 1H, H5), 4.52–4.60 (m, 2H, H6, H6), 5.16 (d, 1H, J = 7.9 Hz, H1), 5.49–5.62 (m, 2H, H2, H4), 5.95 (t, 1H, J = 9.6 Hz, H3), 7.28–7.55 (m, 12H, ArH), 7.85–8.06 (m, 8H, ArH).

Adamentyl 2,3,4,6-tetra-O-benzoyl-β-D-galactopyranoside (65)

The crude mass was purified by silica gel column chromatography (60–120 mesh) (PE/EtOAc 5[thin space (1/6-em)]:[thin space (1/6-em)]1) to get pure product (65) as colourless syrup in 89% yield. 1H NMR (CDCl3, 300 MHz): δ 1.49–1.56 (m, 6H), 1.64–1.71 (m, 3H), 1.84–1.87 (m, 3H), 2.04 (s, 3H), 4.34 (m, 1H, H5), 4.46 (dd, 1H, J = 5.9, 11.0 Hz, H6), 4.59 (dd, 1H, J = 3.1, 10.8 Hz, H6), 5.09 (d, 1H, J = 7.9 Hz, H1), 5.60 (dd, 1H, J = 3.1, 10.2 Hz, H3), 5.78 (app t, 1H, J = 8.2, 9.8 Hz, H2), 5.97 (bs, 1H, H4), 7.23–7.59 (m, 12H, ArH), 7.78–7.80 (d, 2H, J = 7.7 Hz, ArH), 7.95–7.98 (d, 2H, J = 7.5 Hz, ArH), 8.03–8.06 (d, 2H, J = 7.6 Hz, ArH), 8.10–8.13 (d, 2H, J = 7.6 Hz, ArH). 13C NMR (CDCl3, 75 MHz): δ 30.6, 36.1, 42.4, 62.5, 68.4, 69.9, 71.2, 72.2, 75.8, 94.6 (C1) 128.3, 128.37, 128.42, 128.6, 128.9, 129.1, 129.67, 129.72, 129.8, 130.2, 133.1, 133.2, 133.5, 165.6, 165.8, 166.1.

Methyl 2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (67)22d

The crude mass was purified by silica gel column chromatography (60–120 mesh) (PE/EtOAc 5[thin space (1/6-em)]:[thin space (1/6-em)]1) to get pure product (67) as colourless syrup in 91% yield. 1H NMR (CDCl3, 500 MHz): δ 1.92 (s, 6H, COCH3), 1.95 (s, 3H, COCH3), 1.97 (s, 3H, COCH3), 3.28 (m, 1H), 3.34 (s, 3H, OCH3), 3.44 (dd, 1H, J = 4.0, 9.0 Hz), 3.56–3.60 (m, 2H), 3.73 (dd, 1H, J = 3.5, 11.0 Hz), 3.81–3.86 (m, 3H), 4.11 (dd, 1H, J = 4.0, 12.0 Hz), 4.40 (d, 1H, J = 12.0 Hz, BnH), 4.48 (d, 1H, J = 8.0 Hz, H1), 4.55 (d, 1H, J = 3.5 Hz, H1), 4.56 (d, 1H, J = 12.5 Hz, BnH), 4.71 (app t, 3H, J = 11.0, 12.0 Hz, BnH), 4.86 (app t, 1H, J = 8.0, 9.0 Hz, H2), 4.91–5.00 (m, 3H, BnH, H3, H4), 7.21–7.27 (m, 8H, ArH), 7.33–7.39 (m, 7H, ArH). 13C NMR (CDCl3, 75 MHz): δ 20.6 (COCH3), 20.7 (COCH3), 55.4, 67.6, 68.1, 69.7, 71.5, 71.9, 73.2, 73.5, 73.7, 75.2, 78.9, 79.9, 98.4 (C1), 100.0 (C1), 127.2, 127.4, 127.8, 128.1, 128.2, 128.22, 128.4, 128.7, 137.7, 138.3, 139.4, 169.1 (C[double bond, length as m-dash]O), 169.4 (C[double bond, length as m-dash]O), 170.2 (C[double bond, length as m-dash]O), 170.7 (C[double bond, length as m-dash]O).

4-Methoxyphenyl 2,3,4-tri-O-benzoyl-α-D-rhamnopyranosyl-(1→3)-2,4-di-O-benzoyl-α-D-rhamnopyranoside (70)43

The residue was purified by flash column chromatography (PE/EtOAc, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the title compound 70 as colorless syrup (91%); 1H NMR (CDCl3, 300 MHz): δ 1.20 (d, 3H, J = 5.7 Hz), 1.37 (d, 3H, J = 6.0 Hz, CH3), 3.81 (s, 3H, OCH3), 4.18–4.28 (m, 2H), 4.72 (bd, 1H, J = 9.6 Hz), 5.34 (bs, 2H), 5.54 (app t, 1H, J = 9.6, 10.0 Hz), 5.63–5.67 (m, 2H), 5.71–5.74 (m, 2H), 6.88–6.90 (d, 2H, J = 7.2 Hz, ArH), 7.09–7.11 (m, 2H, ArH), 7.20–7.25 (t, 1H, J = 7.2 Hz, ArH), 7.28–7.37 (m, 3H, ArH), 7.39–7.51 (m, 7H, ArH), 7.61–7.63 (m, 3H, ArH), 7.68 (d, 1H, J = 6.2 Hz, ArH), 7.72–7.78 (app t, 4H, J = 8.1, 8.5 Hz, ArH), 7.94–7.96 (d, 2H, J = 6.2 Hz, ArH), 8.15–8.18 (d, 2H, J = 7.8 Hz, ArH), 8.28–8.31 (d, 2H, J = 7.8 Hz, ArH).

Methyl 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→2)-3,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→2)-3,4,6-tri-O-benzyl-α-D-mannopyranoside (73)22f

The residue was purified by flash column chromatography (PE/EtOAc, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the title compound 73 as colorless syrup (90%); [α]25D +10.2 (c 1.5, CHCl3); 1H NMR (300 MHz, CDCl3): δ 2.14 (s, 3H, COCH3), 3.23 (s, 3H, OCH3), 3.53 (d, 1H, J = 10.5 Hz) 3.65–3.84 (m, 9H), 3.87–3.93 (m, 4H), 3.95–3.99 (m, 2H), 4.11 (bs, 1H), 4.32 (d, 1H, J = 12.1 Hz, BnH), 4.41–4.47 (m, 2H), 4.51–4.67 (m, 11H), 4.70 (d, 1H, J = 3.3 Hz), 4.81–4.87 (m, 4H), 5.06 (brs, 1H), 5.21 (brs, 1H), 5.55 (bs, 1H, H′′2), 7.15–7.36 (m, 45H, ArH); 13C NMR (75 MHz, CDCl3): δ 21.2 (COCH3), 54.7 (OCH3), 68.8, 69.6, 71.7, 71.9, 72.1, 72.2, 73.3, 73.4, 74.3, 74.9, 75.0, 75.1, 78.1, 79.3, 79.5, 99.4, 99.8, 100.6, 127.4, 127.5, 127.6, 127.7, 127.8, 127.9, 128.0, 128.16, 128.23, 128.3, 128.4, 138.1, 138.2, 138.4, 138.5, 138.6, 170.1 (C[double bond, length as m-dash]O).

Phenyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (75)33c

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 75 in 85% β only as white solid,33c Rf 0.33 (20% EA in hexane); mp 146–148 °C (from MeOH), lit.33c mp 147–148 °C, [α]25D +11.8 (c 1.05, CHCl3); lit.33c [α]24D +10.4 (c 1.08, CHCl3). 1H NMR (CDCl3, 300 MHz): δ 3.37–3.52 (m, 4H), 3.57–3.92 (m, 7H), 4.08 (appatent t, 1H, J = 9.2, 9.5 Hz), 4.43 (bs, 2H), 4.48–4.68 (m, 5H), 4.72–4.86 (m, 7H), 4.93 (d, 1H, J = 10.8 Hz, BnH), 5.17 (d, 1H, J = 11.1 Hz, BnH), 7.19–7.34 (m, 38H, ArH), 7.58–7.61 (m, 2H, ArH). 13C NMR (CDCl3, 75 MHz): δ 68.3, 68.9, 73.2, 73.3, 74.8, 75.0, 75.5, 75.7, 76.4, 78.1, 80.2, 82.8, 85.0, 87.5 (C1), 102.6 (C1), 127.3, 127.4, 127.5, 127.6, 127.7, 127.9, 128.0, 128.1, 128.2, 128.3, 128.33, 128.4, 128.9, 132.1, 133.8, 138.2, 138.3, 138.4, 138.5, 138.6, 139.2. HRMS (ESI-TOF): calculated for C67H68O10SNa (M + Na) 1087.4431 and found 1087.4414.

Phenyl 2,3-di-O-benzyl-4,6-O-benzyledene-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (76)33d

The crude residue was purified by silica gel (230–400 mesh) flash column chromatography (hexane/ethyl acetate, 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the compound 76 in 94% β as colourless syrup.33d Rf 0.35 (25% EA in hexane); 1H NMR (CDCl3, 300 MHz): δ 3.24 (m, 1H), 3.38–3.54 (m, 4H), 3.60–3.78 (m, 4H), 3.90 (dd, 1H, J = 3.2, 10.9 Hz), 4.04 (t, 1H, J = 9.5 Hz), 4.23 (dd, 1H, J = 4.9, 10.4 Hz), 4.45 (d, 1H, J = 11.9 Hz), 4.58–4.67 (m, 3H), 4.74–4.87 (m, 6H), 4.94 (d, 1H, J = 11.3 Hz), 5.01 (d, 1H, J = 10.7 Hz), 5.53 (s, 1H, PhCH), 7.27–7.61 (m, 35H, ArH). 13C NMR (CDCl3, 75 MHz): δ 62.4, 68.2, 70.7, 73.4, 74.9, 75.3, 75.5, 75.6, 76.6, 79.3, 82.5, 84.8, 87.5 (C1), 101.4 (PhCH), 102.6 (C1), 126.1, 127.3, 127.5, 127.6, 127.7, 127.8, 127.9, 127.98, 128.2, 128.3, 128.4, 128.6, 128.9, 129.0, 129.7, 132.1, 138.2, 138.5. HRMS (ESI-TOF): calculated for C60H60O10SNa (M + Na) 995.3805 and found 995.3810.

Phenyl 2-O-acetyl-3,4,6-tri-O-benzyl-α-D-mannopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-1-thio-α-D-mannopyranoside (79)22d

The crude residue was purified by silica gel flash column chromatography (hexane/ethyl acetate, 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 79 (94%) as a white foam.22d Rf = 0.25 (30% ethyl acetate in hexane); [α]26D +16.3 (c 1.34, CHCl3); 1H NMR (600 MHz, CDCl3): δ 2.10 (s, 3H, COCH3), 3.53 (d, 1H, J = 9.6 Hz), 3.68 (m, 1H), 3.69 (m, 1H), 3.75 (dd, 1H, J = 3.0, 10.2 Hz), 3.87 (t, 1H, J = 9.6 Hz), 3.95 (dd, 1H, J = 3.6, 9.6 Hz), 4.00 (dd, 1H, J = 5.4, 10.8 Hz), 4.32 (d, 1H, J = 10.8 Hz), 4.36 (d, 1H, J = 12.0 Hz), 4.44 (d, 1H, J = 10.8 Hz), 4.50 (d, 1H, J = 10.8 Hz), 4.58 (d, 1H, J = 12.0 Hz), 4.81 (m, 1H), 4.84 (d, 1H, J = 10.8 Hz), 4.87 (d, 1H, J = 1.3 Hz, H1), 5.36 (dd, 1H, J = 1.8, 3.0 Hz), 5.73 (d, 1H, J = 1.2 Hz, H1), 5.81 (dd, 1H, J = 3.0, 9.6 Hz), 5.94 (m, 1H), 5.99 (t, 1H, J = 10.2 Hz), 7.13–7.16 (m, 3H, ArH), 7.22–7.35 (m, 17H, ArH), 7.41–7.57 (m, 9H, ArH), 7.85 (d, 2H, J = 7.2 Hz, ArH), 8.00 (d, 2H, J = 7.2 Hz, ArH), 8.07 (d, 2H, J = 7.2 Hz, ArH). 13C NMR (150 MHz, CDCl3): δ 21.0, 66.6, 67.3, 68.44, 68.46, 70.45, 70.48, 71.5, 71.8, 72.0, 73.2, 74.0, 75.1, 78.4, 86.0 (C1) 98.0 (C1) 127.50, 127.51, 127.7, 127.88, 127.90, 128.0, 128.18, 128.23, 128.27, 128.32, 128.4, 128.47, 128.54, 128.6, 128.9, 129.2, 129.3, 129.4, 129.71, 129.8, 129.74, 129.89, 129.9, 131.5, 132.1, 133.22, 133.25, 133.5, 133.6, 137.9, 138.0, 138.5, 165.3 (C[double bond, length as m-dash]O), 165.4 (C[double bond, length as m-dash]O), 170.3 (C[double bond, length as m-dash]O); HRMS (ESI-TOF): calculated for C62H58O14SNa [M + Na]+ 1081.3445 found 1081.3441.

Phenyl 2-O-benzoyl-3,4-di-O-benzyl-α-L-rhamnopyranosyl-(1→2)-3,4-di-O-benzyl-1-thio-α-L-rhamnopyranoside (82)

The crude residue was purified by silica gel flash column chromatography (hexane/ethyl acetate, 9[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 82 (92%) as a white foam. Rf = 0.25 (10% ethyl acetate in hexane); 1H NMR (300 MHz, CDCl3): δ 1.32 (d, 3H, J = 5.8 Hz, CH3), 1.36 (d, 3H, J = 6.1 Hz, CH3), 3.53–3.61 (m, 2H, H4, H4), 3.89–3.93 (m, 2H, H3, H5), 4.11–4.19 (m, 2H, H5, H3), 4.25 (bs, 1H, H2), 4.62–4.69 (m, 3H, BnH), 4.73–4.76 (m, 2H, BnH), 4.85–4.99 (m, 3H, BnH), 5.12 (bs, 1H, H1), 5.51 (bs, 1H, H1), 5.80 (bs, 1H, H2), 7.24–7.64 (m, 28H, ArH), 8.13–8.15 (d, 2H, J = 7.1 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ 18.0 (CH3), 18.1 (CH3), 68.5, 69.4, 69.5, 71.7, 74.4, 75.4, 77.8, 80.7, 80.1, 80.2, 87.3 (C1), 99.7 (C1), 127.3, 127.6, 127.7, 127.8, 128.1, 128.2, 128.3, 128.4, 128.5, 128.6, 129.1, 129.9, 130.1, 131.3, 133.2, 134.6, 138.1, 138.1, 138.4, 138.5, 165.6 (C[double bond, length as m-dash]O).

p-Methylphenyl 2,3,4-tri-O-benzyl-α-L-fucopyranosyl-(1→4)-2,3,6-tri-O-benzoyl-1-thio-β-D-glucopyranoside (85)44

The product was purified by flash chromatography (PE/EtOAc 5[thin space (1/6-em)]:[thin space (1/6-em)]1) on silica gel (230–400 mesh) to give 85 in 88% yield as colorless syrup. [α]27D −10.5 (c 1.2, CHCl3); lit.44 [α]24D −8.2 (c 0.98, CHCl3); 1H (300 MHz, CDCl3): δ 0.59 (d, 3H, J = 6.4 Hz, CH3), 2.23 (s, 3H, PhCH3), 3.45 (bs, 1H, H4), 3.70 (m, 1H, H5), 3.86–3.98 (m, 4H, H4, H5, H2, H3), 4.50 (d, 1H, J = 11.5 Hz, BnH), 4.61–4.86 (m, 8H, 5BnH, H1, H6, H1), 5.06 (d, 1H, J = 10.9 Hz, H6), 5.23 (t, 1H, J = 9.7 Hz, H2), 5.69 (t, 1H, J = 8.9 Hz, H3), 6.86 (d, 2H, J = 8.0 Hz, ArH), 7.21–7.23 (m, 7H, ArH), 7.25–7.35 (m, 11H, ArH), 7.38–7.44 (m, 4H, ArH), 7.47–7.53 (m, 3H, ArH), 7.62–7.64 (m, 1H, ArH), 7.83–7.85 (d, 2H, J = 7.4 Hz, ArH), 7.88–7.91 (d, 2H, J = 7.3 Hz, ArH), 8.06–8.09 (d, 2H, J = 7.3 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ 15.9, 21.1, 63.1, 67.7, 70.9, 72.7, 74.3, 74.8, 75.6, 75.7, 76.3, 77.2, 77.6, 77.8, 79.2, 85.5 (C1), 100.5 (C1), 127.4, 127.5, 127.7, 128.1, 128.2, 128.3, 128.4, 128.41, 129.3, 129.5, 129.8, 129.9, 130.1, 133.0, 133.1, 133.9, 138.1, 138.3, 138.4, 138.6.

Preparation of trisaccharide 2,3,4.6-tetra-O-benzyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-β-D-glucopyranosyl-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (39)19c

Via sequential one-pot glycosylation technique. A 25 mL oven-dried round bottom flask was charged with 2,3,4,6-tetra-O-benzyl-D-glucopyranosyl trichloroacetimidate donor 1 (155 mg, 0.227 mmol, 1.2 equiv.), 4′-methyl phenyl 2,3,4-tri-O-benzoyl-1-thio-α-D-glucopyranoside 86 (100 mg, 0.189 mmol, 1 equiv.), and CH2Cl2 (5 mL). The resulting solution was stirred on freshly dried 4 Å molecular sieves for 40 min at room temperature under argon atmosphere. Then this mixture was cooled to −60 °C, FeCl3 (3.4 mg, 0.024 mmol, 0.1 equiv.) was added, and the reaction mass was allowed to achieve room temperature. After the acceptor was consumed completely (checked by TLC), to the reaction mass 1,2:3,4-diisopropyl-α-D-galactopyranoside 8 (40 mg, 0.151 mmol, 0.8 equiv.) was injected and was cooled on ice bath NIS (45 mg, 0.227 mmol, 1 equiv.) and FeCl3 (4 mg, 0.024 mmol, 0.1 equiv.) was added one by one. After 15 min TLC was checked and the acceptor was consumed completely. Then molecular sieves were filtered off through celite bed. The filtrate was diluted with CH2Cl2 and washed subsequently with saturated NaHCO3 solution and water. The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the glycosylated product. The crude residue was purified by silica gel flash column chromatography (hexane/EtOAc, 3[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford 39 (196 mg, 87.3%) as a white foam. Spectroscopic data match with previous one and reported one.

Methyl 3,4,6-tri-O-benzyl-2-O-methyl-β-D-glucopyranosyl-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (88)

The residue was purified by flash column chromatography (PE/EA, 4[thin space (1/6-em)]:[thin space (1/6-em)]1) to afford the title compound 88 as colorless syrup (93%); 1H NMR (CDCl3, 300 MHz): δ 3.19 (app t, 1H, J = 7.9, 9.1 Hz, H2), 3.46 (m, 1H, H5), 3.61 (s, 3H, OCH3), 3.68 (s, 3H, OCH3) 3.56–3.72 (m, 4H, H3, H4, H6, H6), 3.90 (dd, 1H, J = 8.4, 11.5 Hz, H6), 4.14–4.18 (m, 2H, H5, H6), 4.46 (d, 1H, J = 7.9 Hz, H1), 4.52–4.62 (m, 3H, 3 × BnH), 4.78–4.97 (m, 4H, 3Bn × H, H1), 5.49 (t, 1H, J = 9.6 Hz, H4), 5.56 (t, 1H, J = 7.9 Hz, H2), 5.96 (t, 1H, J = 9.6 Hz, H3), 7.20–7.23 (m, 2H, ArH), 7.28–7.45 (m, 20H, ArH), 7.52–7.57 (t, 2H, J = 7.3 Hz, ArH), 7.86–7.88 (t, 2H, J = 7.6 Hz, ArH), 7.97–8.04 (m, 4H, ArH). 13C NMR (CDCl3, 75 MHz): δ 57.2, 60.5, 70.1, 72.0, 73.1, 73.5, 74.2, 74.8, 75.0, 75.6, 77.5, 84.2, 84.7, 102.0 (JC-H = 155.9 Hz, C1) 104.1 (JC-H = 157.1 Hz, C1), 127.6, 127.7, 127.77, 127.82, 127.98, 128.01, 128.3, 128.39, 128.42, 128.5, 128.9, 129.4, 129.8, 129.9, 133.2, 133.5, 138.1, 138.2, 138.8, 165.2 (C[double bond, length as m-dash]O), 165.4 (C[double bond, length as m-dash]O), 165.9 (C[double bond, length as m-dash]O).

Methyl 3,4,6-tri-O-benzyl-2-deoxy-α-D-glucopyranosyl-(1→3)-2-O-benzyl-4,6-O-benzylidene-α-D-glucopyranoside (90)32

The product was purified by flash chromatography (PE/EA 4[thin space (1/6-em)]:[thin space (1/6-em)]1) on silica gel (100–200 mesh) to give 90 in 87% yield as colourless syrup. 1H (500 MHz, CDCl3): δ 1.60 (dt, 1H, J = 3.5, 12.5 Hz, H2a), 2.23 (dd, 1H, J = 4.5, 12.5 Hz, H2e), 3.29 (s, 3H, OCH3), 3.36 (dd, 1H, J = 3.5, 9.5 Hz), 3.45–3.49 (m, 2H), 3.54–3.62 (m, 3H), 3.71 (m, 1H), 3.91 (m, 1H), 4.01 (d, 1H, J = 9.5 Hz), 4.14–4.19 (m, 2H), 4.29 (d, 1H, J = 12.0 Hz, BnH), 4.42 (d, 1H, J = 11.0 Hz, BnH), 4.44 (d, 1H, J = 11 Hz, BnH), 4.51–4.60 (m, 5H, 4 × BnH, H1), 4.79 (d, 1H, J = 11.0 Hz, BnH), 5.41 (d, 1H, J = 4.5 Hz, H1), 5.42 (s, 1H, PhCH) 7.07–7.37 (m, 25H, ArH). 13C NMR (CDCl3, 75 MHz): δ 35.4, 55.3, 61.9, 68.6, 70.7, 71.6, 72.7, 73.4, 73.7, 74.7, 77.4, 78.1, 78.3, 82.9, 97.6, 98.8, 101.4, 126.0, 127.3, 127.4, 127.5, 127.6, 127.7, 127.9, 128.1, 128.15, 128.2, 128.3, 128.4, 128.6, 129.0, 129.8, 134.5, 137.3, 137.7, 138.3, 138.9, 139.1.

Acknowledgements

Financial support from DST-SERB (Scheme No. SR/S1/OC-61/2012), New Delhi, India to RG, from CAS-UGC and FIST-DST, India, to the Department of Chemistry, Jadavpur University are acknowledged. MMM (SRF) is grateful to UGC, India for fellowship.

References

  1. (a) A. Varki, R. D. Cummings, J. D. Esko, H. H. Freeze, P. Stanley, C. R. Bertozzi, G. W. Hart and M. E. Etzler, Essentials of Glycobiology, Cold Spring Harbor Press, New York, 2009 Search PubMed; (b) R. A. Dwek, Chem. Rev., 1996, 96, 683 CrossRef CAS PubMed; (c) A. Varki, Glycobiology, 1993, 3, 97 CrossRef CAS PubMed.
  2. (a) B. Fraser-Reid, Z. Wu, U. E. Udodong and H. Ottosson, J. Org. Chem., 1990, 55, 6068 CrossRef CAS; (b) K. Toshima and K. Tatsuta, Chem. Rev., 1993, 93, 1503 CrossRef CAS.
  3. (a) H. Kunz and A. Harreus, Liebigs Ann. Chem., 1982, 41 CrossRef CAS; (b) S. Sato, S. Nunomura, T. Nakano, Y. Ito and T. Ogawa, Tetrahedron Lett., 1988, 33, 4097 CrossRef; (c) P. H. Seeberger, M. Eckhardt, C. E. Gutteridge and S. J. Danishefsky, J. Am. Chem. Soc., 1997, 119, 10064 CrossRef CAS; (d) D. Crich, Z. Dai and S. J. Gastaldi, J. Org. Chem., 1999, 64, 5224 CrossRef CAS.
  4. H. Yu and H. E. Ensley, Tetrahedron Lett., 2003, 4, 9363 CrossRef.
  5. M. Jacobsson, J. Malmberg and U. Ellervik, Carbohydr. Res., 2006, 341, 1266 CrossRef CAS PubMed.
  6. T. Bililign, B. R. Griffith and J. S. Thorson, Nat. Prod. Rep., 2005, 22, 475 RSC.
  7. M. J. McKay, B. D. Nab, G. J. Mercer and H. M. Nguyen, J. Org. Chem., 2009, 74, 4705 CrossRef CAS PubMed.
  8. (a) R. R. Schmidt and J. Michel, Angew. Chem., Int. Ed., 1980, 19, 731 CrossRef; (b) R. R. Schmidt and W. Kinzy, Adv. Carbohydr. Chem. Biochem., 1994, 50, 121 CrossRef; (c) Y. Geng, A. Kumar, H. M. Faidallah, H. A. Albar, I. A. Mhkalid and R. R. Schmidt, Angew. Chem., Int. Ed., 2013, 52, 10089 CrossRef CAS PubMed.
  9. (a) R. R. Schmidt, Angew. Chem., Int. Ed., 1986, 25, 212 CrossRef; (b) R. H. Huixin, J. A. Vasella and P. Weiss, Helv. Chim. Acta, 1996, 79, 1757 CrossRef; (c) V. J. Patil, Tetrahedron Lett., 1996, 37, 1481 CrossRef CAS.
  10. A. Dobarro-Rodriguez, M. Trumtel and H. P. Wessel, J. Carbohydr. Chem., 1992, 11, 255 CrossRef CAS.
  11. F. J. Ubran, B. S. Moore and R. Breitenbach, Tetrahedron Lett., 1990, 31, 4421 CrossRef.
  12. A. Sau, A. Santra and A. K. Misra, Synlett, 2012, 23, 2341 CrossRef CAS.
  13. (a) M. Adinolfi, G. Baroni, L. Guarineelo and A. Iadonise, Tetrahedron Lett., 2000, 41, 9005 CrossRef CAS; (b) M. Adinolfi, G. Barone, A. Iadonisi and M. Schiattarella, Synlett, 2002, 269 CrossRef CAS; (c) M. Adinolfi, G. Barone, A. Iadonisi and M. Schiattarella, Org. Lett., 2003, 5, 987 CrossRef CAS PubMed; (d) M. Adinolfi, G. Barone, A. Iadonisi and M. Schiattarella, J. Org. Chem., 2005, 70, 5316 CrossRef CAS PubMed.
  14. H. Waldmann, G. Böhm, U. Schmid and H. Röttele, Angew. Chem., Int. Ed., 1994, 33, 1944 CrossRef.
  15. A. Lubineau and B. Drouillat, J. Carbohydr. Chem., 1997, 16, 1179 CrossRef CAS.
  16. B. Mukhopadhyay, S. V. Maurer, N. Rudolph, R. M. van Well, D. A. Russell and R. A. Field, J. Org. Chem., 2005, 70, 9059 CrossRef CAS PubMed.
  17. Q. Tian, S. Zhang, W. Yu, M. B. He and J. S. Yang, Tetrahedron, 2007, 63, 2142 CrossRef CAS.
  18. R. Roy, A. K. Palanivel, A. Mallick and Y. D. Vankar, Eur. J. Org. Chem., 2015, 4000 CrossRef CAS.
  19. (a) M. J. McKay and H. M. Nguyen, ACS Catal., 2012, 2, 1563 CrossRef CAS PubMed; (b) J. Yang, C. Cooper-Vanosdell, E. A. Mensah and H. M. Nguyen, J. Org. Chem., 2008, 73, 794 CrossRef CAS PubMed; (c) E. A. Mensah, J. M. Azzarelli and H. M. Nguyen, J. Org. Chem., 2009, 74, 1650 CrossRef CAS PubMed; (d) E. A. Mensah, F. Yu and H. M. Nguyen, J. Am. Chem. Soc., 2010, 132, 14288 CrossRef CAS PubMed.
  20. (a) D. J. Cox, M. D. Smith and A. J. Fairbank, Org. Lett., 2010, 12, 1452 CrossRef CAS PubMed; (b) S. Medina, A. S. Henderson, J. F. Bower and M. C. Galan, Chem. Commun., 2015, 51, 8939 RSC.
  21. P. Peng and R. R. Schmidt, J. Am. Chem. Soc., 2015, 137, 12653 CrossRef CAS PubMed.
  22. (a) S. K. Maity, A. Patra and R. Ghosh, Tetrahedron, 2010, 66, 2809 CrossRef CAS; (b) N. Basu, S. K. Maity and R. Ghosh, RSC Adv., 2012, 2, 12661 RSC; (c) R. Ghosh, A. Chakraborty, D. K. Maiti and V. G. Puranik, Org. Lett., 2006, 8, 1061 CrossRef CAS PubMed; (d) S. K. Maity, N. Basu and R. Ghosh, Carbohydr. Res., 2012, 354, 40 CrossRef CAS PubMed; (e) S. K. Maity and R. Ghosh, Synlett, 2012, 23, 1919 CrossRef CAS; (f) M. M. Mukherjee, N. Basu and R. Ghosh, RSC Adv., 2016, 6, 45112 RSC; (g) N. Basu, M. M. Mukherjee, A. Chaudhury and R. Ghosh, J. Indian Chem. Soc., 2013, 90, 1815 CAS; (h) N. Basu, M. M. Mukherjee and R. Ghosh, RSC Adv., 2014, 4, 54084 RSC.
  23. (a) C. Bolm, J. Legros, L. Paith and L. Zani, Chem. Rev., 2004, 104, 6217 CrossRef CAS PubMed; (b) D. Diaz, P. Miranda, J. Pardón and V. Martín, Curr. Org. Chem., 2006, 10, 457 CrossRef; (c) D. Sherry and A. Fürstner, Acc. Chem. Res., 2008, 41, 1500 CrossRef PubMed; (d) E. B. Bauer, Curr. Org. Chem., 2008, 12, 1341 CrossRef CAS; (e) Y. Bourdreux, A. Lemétais, D. Urban and J.-M. Beau, Chem. Commun., 2011, 47, 2146 RSC; (f) A. A. O. Sarhanw and C. Bolm, Chem. Soc. Rev., 2009, 38, 2730 RSC; (g) S. H. Chow, J. Y. Kim, J. Kwak and S. Chang, Chem. Soc. Rev., 2011, 40, 5068 RSC; (h) K. Paul, K. Bera, S. Jalal, S. Sarkar and U. Jana, Org. Lett., 2014, 16, 2166 CrossRef CAS PubMed; (i) I. Bauer and H.-J. Knölker, Chem. Rev., 2015, 115, 3170 CrossRef CAS PubMed.
  24. (a) A. M. d'Hardemare, S. Torelli, G. Serratrice and J.-L. Pierre, BioMetals, 2006, 19, 349 CrossRef PubMed; (b) S. Sarkar, K. Bera, S. Jalal and U. Jana, Eur. J. Org. Chem., 2013, 6055 CrossRef CAS; (c) P. Beret, V. Beaujolais, C. Béguin, D. Gaude, J.-L. Pierre and G. Serratrice, Eur. J. Inorg. Chem., 1998, 613 CrossRef; (d) J. Christoffers, Chem. Commun., 1997, 943 RSC.
  25. S. Houdier and P. J. A. Vottere, Carbohydr. Res., 1992, 232, 349 CrossRef CAS.
  26. (a) Y. Watanabe, C. Nakamoto, T. Yamamoto and S. Ozaki, Tetrahedron, 1994, 50, 6523 CrossRef CAS; (b) T. Yamanoi, Y. Iwai and T. Inazu, J. Carbohydr. Chem., 1998, 17, 819 CrossRef CAS.
  27. (a) D. Crich and S. Sun, J. Am. Chem. Soc., 1998, 120, 435 CrossRef CAS; (b) D. Kahne, S. Walker, Y. Cheng and D. van Engen, J. Am. Chem. Soc., 1989, 111, 6881 CrossRef CAS.
  28. J. D. C. Codée, R. E. J. N. Litjens, L. J. van den Bos, H. S. Overkleet and G. A. van den Marel, Chem. Soc. Rev., 2005, 34, 769 RSC.
  29. (a) Z. Zhang, I. R. Ollmann, X.-Y. Ye, R. Wischnat, T. Baasov and C.-H. Wong, J. Am. Chem. Soc., 1999, 121, 734 CrossRef CAS; (b) Y. H. Wang, X. S. Ye and L. H. Zhang, Org. Biomol. Chem., 2007, 5, 2189 RSC.
  30. D. Crich and V. Dudkin, Tetrahedron Lett., 2000, 41, 5643 CrossRef CAS.
  31. I. Sharma, L. Bohé and D. Crich, Carbohydr. Res., 2012, 357, 126 CrossRef CAS PubMed.
  32. A. A.-H. Chu, A. Minciunescu, V. Montanari, K. Kumar and C. S. Bennett, Org. Lett., 2014, 16, 1780 CrossRef CAS PubMed.
  33. (a) J. Tatai and P. Fügedi, Org. Lett., 2007, 9, 4647 CrossRef CAS PubMed; (b) B. A. Garcia and D. Y. Gin, J. Am. Chem. Soc., 2000, 122, 4269 CrossRef CAS; (c) A. Nakagawa, H. Kamitakahara and T. Takano, Carbohydr. Res., 2011, 346, 1671 CrossRef CAS PubMed; (d) H. Kamitakahara, F. Nakatsubo and D. Klemm, Cellulose, 2007, 14, 543 CrossRef.
  34. H. D. Premathilake and A. V. Demchenko, Beilstein J. Org. Chem., 2012, 8, 597 CrossRef CAS PubMed.
  35. M. Goswami, A. Ellern and N. L. B. Pohl, Angew. Chem., Int. Ed., 2013, 52, 8441 CrossRef CAS PubMed.
  36. K.-T. Hang and N. Winssinger, Eur. J. Org. Chem., 2007, 1887 CrossRef.
  37. (a) D. C. Xiong, L. H. Zhang and X. S. Ye, Adv. Synth. Catal., 2008, 350, 1696 CrossRef CAS; (b) P. Peng and X.-S. Ye, Org. Biomol. Chem., 2011, 9, 616 RSC.
  38. S. Valerio, A. Iadonisi, M. Adinolfi and A. Ravida, J. Org. Chem., 2007, 72, 6097 CrossRef CAS PubMed.
  39. D. Crich, M. de la Mora and A. U. Vinod, J. Org. Chem., 2003, 68, 8142 CrossRef CAS PubMed.
  40. M. J. McKay, B. D. Naab, G. J. Mercer and H. M. Nguyen, J. Org. Chem., 2009, 74, 4705 CrossRef CAS PubMed.
  41. I. J. Talisman, V. Kumar, J. R. Deschamps, M. Frisch and S. V. Malhotra, Carbohydr. Res., 2011, 346, 2337 CrossRef CAS PubMed.
  42. (a) S. Adhikari, X. Li and J. Zhu, J. Carbohydr. Chem., 2013, 32, 336 CrossRef CAS; (b) K. Kawa, T. Saitoh, E. Kaji and S. Nishitama, Org. Lett., 2013, 15, 5484 CrossRef CAS PubMed.
  43. R. Fauré, T. C. Shiao, D. Lagnoux, D. Giguére and R. Roy, Org. Biomol. Chem., 2007, 5, 2704 Search PubMed.
  44. S. G. Durón, T. Polat and C.-H. Wong, Org. Lett., 2004, 6, 839 CrossRef PubMed.

Footnotes

Electronic supplementary information (ESI) available. CCDC 1501233. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c6ra21859h
At present: Department of Organic Chemistry, IACS, Jadavpur, Kolkata 700032, India.

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.